<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">FEBS Open Bio</journal-id><journal-id journal-id-type="iso-abbrev">FEBS Open Bio</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2211-5463</journal-id><journal-id journal-id-type="publisher-id">FEB4</journal-id><journal-title-group><journal-title>FEBS Open Bio</journal-title></journal-title-group><issn pub-type="epub">2211-5463</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5458457</article-id><article-id pub-id-type="doi">10.1002/2211-5463.12219</article-id><article-id pub-id-type="publisher-id">FEB412219</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>The neuronal and astrocytic protein <styled-content style="fixed-case">SLC</styled-content>38A10 transports glutamine, glutamate, and aspartate, suggesting a role in neurotransmission</article-title><alt-title alt-title-type="left-running-head">S. V. Hellsten <italic>et&#x000a0;al</italic>.</alt-title></title-group><contrib-group><contrib id="feb412219-cr-0001" contrib-type="author" corresp="yes"><name><surname>Hellsten</surname><given-names>Sofie V.</given-names></name><address><email>Sofie.Hellsten@farmbio.uu.se</email></address><xref ref-type="aff" rid="feb412219-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="feb412219-cr-0002" contrib-type="author"><name><surname>H&#x000e4;gglund</surname><given-names>Maria G.</given-names></name><xref ref-type="aff" rid="feb412219-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="feb412219-cr-0003" contrib-type="author"><name><surname>Eriksson</surname><given-names>Mikaela M.</given-names></name><xref ref-type="aff" rid="feb412219-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="feb412219-cr-0004" contrib-type="author"><name><surname>Fredriksson</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="feb412219-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="feb412219-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Pharmaceutical Bioscience, Molecular Neuropharmacology</named-content><institution>Uppsala University</institution><country country="SE">Sweden</country></aff><aff id="feb412219-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Department of Neuroscience, Functional Pharmacology</named-content><institution>Uppsala University</institution><country country="SE">Sweden</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
S.&#x000a0;V.&#x000a0;Hellsten, Department of Pharmaceutical Bioscience, Molecular Neuropharmacology, Uppsala University, Uppsala SE 75124, Sweden<break/>
Tel: +4618 471 42 25<break/>
E&#x02010;mail: <email>Sofie.Hellsten@farmbio.uu.se</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2017</year></pub-date><volume>7</volume><issue>6</issue><issue-id pub-id-type="doi">10.1002/feb4.2017.7.issue-6</issue-id><fpage>730</fpage><lpage>746</lpage><history><date date-type="received"><day>03</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>03</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>08</day><month>3</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Federation of European Biochemical Societies <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. Published by FEBS Press and John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:FEB4-7-730.pdf"/><abstract id="feb412219-abs-0001"><p>In brain cells, glutamine transporters are vital to monitor and control the levels of glutamate and <styled-content style="fixed-case">GABA</styled-content>. There are 11 members of the <styled-content style="fixed-case">SLC</styled-content>38 family of amino acid transporters of which eight have been functionally characterized. Here, we report the first histological and functional characterization of the previously orphan member, <styled-content style="fixed-case">SLC</styled-content>38A10. We used pairwise global sequence alignments to determine the sequence identity between the <styled-content style="fixed-case">SLC</styled-content>38 family members. <styled-content style="fixed-case">SLC</styled-content>38A10 was found to share 20&#x02013;25% transmembrane sequence identity with several family members, and was predicted to have 11 transmembrane helices. <styled-content style="fixed-case">SLC</styled-content>38A10 immunostaining was abundant in mouse brain using a custom&#x02010;made anti&#x02010;<styled-content style="fixed-case">SLC</styled-content>38A10 antibody and colocalization of <styled-content style="fixed-case">SLC</styled-content>38A10 immunoreactivity with markers for neurons and astrocytes was detected. Using <italic>Xenopus&#x000a0;laevis</italic> oocytes overexpressing <styled-content style="fixed-case">SLC</styled-content>38A10, we show that <styled-content style="fixed-case">SLC</styled-content>38A10 mediates bidirectional transport of <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamate, and <sc>d</sc>&#x02010;aspartate, and efflux of <sc>l</sc>&#x02010;serine. This profile mostly resembles system A members of the <styled-content style="fixed-case">SLC</styled-content>38 family. In conclusion, the bidirectional transport of glutamine, glutamate, and aspartate by <styled-content style="fixed-case">SLC</styled-content>38A10, and the immunostaining detected in neurons and astrocytes, suggest that <styled-content style="fixed-case">SLC</styled-content>38A10 plays a role in pathways involved in neurotransmission.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="feb412219-kwd-0001">glutamate/<styled-content style="fixed-case">GABA</styled-content>&#x02010;glutamine cycle</kwd><kwd id="feb412219-kwd-0002">glutamine transport</kwd><kwd id="feb412219-kwd-0003">immunohistochemistry</kwd><kwd id="feb412219-kwd-0004"><styled-content style="fixed-case">SLC</styled-content>38A10</kwd><kwd id="feb412219-kwd-0005">solute carriers</kwd></kwd-group><funding-group><award-group><funding-source>Swedish Research Council</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Swedish Brain Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Swedish Society for Medical Research</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Novo Nordisk Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>&#x000c5;hlens Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Olle Engkvist Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Thurings Foundation for Metabolic Research</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Gunvor and Josef An&#x000e9;rs Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Tore Nilssons Foundation</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Magnus Bergvalls Foundation</funding-source></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><page-count count="17"/><word-count count="9271"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>feb412219</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.0 mode:remove_FC converted:05.06.2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><def-list list-content="abbreviations" id="feb412219-dl-0001"><title>Abbreviations</title><def-item><term>EAAT</term><def><p>excitatory amino acid transporter</p></def></def-item><def-item><term>GGGC</term><def><p>glutamate/GABA&#x02010;glutamine cycle</p></def></def-item><def-item><term>IHC</term><def><p>immunohistochemistry</p></def></def-item><def-item><term>mTORC1</term><def><p>mechanistic target of rapamycin complex 1</p></def></def-item><def-item><term>SLC</term><def><p>solute carrier</p></def></def-item><def-item><term>SNAT</term><def><p>sodium&#x02010;coupled neutral amino acid transporter</p></def></def-item><def-item><term>TMHs</term><def><p>transmembrane helices</p></def></def-item></def-list><p>Membrane&#x02010;bound transporters are responsible for uptake and efflux of solutes, for example, amino acids, in cells and organelles <xref rid="feb412219-bib-0001" ref-type="ref">1</xref>. In the central nervous system, amino acid transporters also play an important role as transporters for neurotransmitters, for example, glutamate and aspartate and precursors for neurotransmitter synthesis <xref rid="feb412219-bib-0002" ref-type="ref">2</xref>. Furthermore, amino acid transporters can also function as nutrient sensors, and because of their transport and sensing functions they can control the protein synthesis, by either increase or decrease synthesis, depending on nutrient availability <xref rid="feb412219-bib-0003" ref-type="ref">3</xref>, <xref rid="feb412219-bib-0004" ref-type="ref">4</xref>.</p><p>The Solute carrier (SLC) superfamily is the largest group of transporters in the human genome, and up to date, 395 SLCs are identified and divided into 52 families, with different biochemical properties <xref rid="feb412219-bib-0001" ref-type="ref">1</xref>. The members in each SLC family have at least 20% amino acid sequence identity to another member in the family <xref rid="feb412219-bib-0005" ref-type="ref">5</xref>. SLC transporters are membrane&#x02010;bound, located to the plasma membrane <xref rid="feb412219-bib-0006" ref-type="ref">6</xref>, vesicles <xref rid="feb412219-bib-0007" ref-type="ref">7</xref>, lysosomes <xref rid="feb412219-bib-0008" ref-type="ref">8</xref>, peroxisomes <xref rid="feb412219-bib-0009" ref-type="ref">9</xref>, and mitochondria <xref rid="feb412219-bib-0010" ref-type="ref">10</xref>, and function as ATP&#x02010;independent uniporters, symporters, or antiporters. SLCs have a wide substrate profile and mediate flux of for example amino acids, ions, drugs, nucleotides, fatty acids, and vitamins <xref rid="feb412219-bib-0001" ref-type="ref">1</xref>.</p><p>The SLC38 family, the system A and system N sodium&#x02010;coupled neutral amino acid transporter family, has 11 members, encoded by the genes, <italic>SLC38A1&#x02013;SLC38A11</italic>
<xref rid="feb412219-bib-0011" ref-type="ref">11</xref>. The characterized members are termed SNAT# (SLC38A#), Sodium coupled Neutral Amino acid Transporter# <xref rid="feb412219-bib-0012" ref-type="ref">12</xref>, and up to date, eight members are functionally characterized. The transporters in the family are divided into system A or system N, depending on transport characteristics <xref rid="feb412219-bib-0011" ref-type="ref">11</xref>. System A transporters have a wider substrate profile and transport small neutral amino acids, in particular glutamine, alanine, and serine <xref rid="feb412219-bib-0013" ref-type="ref">13</xref>. The system N transporters have a more restricted substrate profile, and translocate mainly glutamine, asparagine, and histidine <xref rid="feb412219-bib-0014" ref-type="ref">14</xref>. Both the system A transporter SLC38A2 and the system N transporter SLC38A5 are pH dependent, with highest activity at pH 8 <xref rid="feb412219-bib-0015" ref-type="ref">15</xref>. However, the transport mechanism differs. System A transport of amino acids is sodium coupled <xref rid="feb412219-bib-0016" ref-type="ref">16</xref>, while the movement of amino acids by system N is sodium coupled with hydrogen in exchange <xref rid="feb412219-bib-0017" ref-type="ref">17</xref>. Furthermore, only system A transporters are affected by the amino acid analog Metyl&#x02010;amino&#x02010;isobutyric acid (MeAIB) <xref rid="feb412219-bib-0018" ref-type="ref">18</xref>. Glutamine is a preferred substrate throughout the family <xref rid="feb412219-bib-0011" ref-type="ref">11</xref>, except for SLC38A4, which mainly transports alanine, asparagine, and cysteine <xref rid="feb412219-bib-0019" ref-type="ref">19</xref>. SLC38A1 <xref rid="feb412219-bib-0020" ref-type="ref">20</xref>, SLC38A2 <xref rid="feb412219-bib-0021" ref-type="ref">21</xref>, SLC38A4 <xref rid="feb412219-bib-0019" ref-type="ref">19</xref>, and SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref> are characterized to system A, while SLC38A3 <xref rid="feb412219-bib-0017" ref-type="ref">17</xref>, SLC38A5 <xref rid="feb412219-bib-0023" ref-type="ref">23</xref>, and SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref> are classified to system N. SLC38A9 is not classified into any system yet, but was recently characterized as a component of the amino acid&#x02010;sensing Ragulator&#x02013;Rag complex on lysosomes, controlling the activation of the mechanistic target of Rapamycin complex 1 (mTORC1) in response to amino acids <xref rid="feb412219-bib-0008" ref-type="ref">8</xref>, <xref rid="feb412219-bib-0025" ref-type="ref">25</xref>, <xref rid="feb412219-bib-0026" ref-type="ref">26</xref> and shown to transport glutamine, arginine, and asparagine <xref rid="feb412219-bib-0008" ref-type="ref">8</xref>.</p><p>In the brain, SLC38A1 <xref rid="feb412219-bib-0020" ref-type="ref">20</xref>, <xref rid="feb412219-bib-0027" ref-type="ref">27</xref>, <xref rid="feb412219-bib-0028" ref-type="ref">28</xref>, <xref rid="feb412219-bib-0029" ref-type="ref">29</xref> and SLC38A2 <xref rid="feb412219-bib-0030" ref-type="ref">30</xref> are expressed in both neurons and astrocytes, while SLC38A3 <xref rid="feb412219-bib-0031" ref-type="ref">31</xref> and SLC38A5 <xref rid="feb412219-bib-0032" ref-type="ref">32</xref> are selectively astrocytic, and SLC38A6 <xref rid="feb412219-bib-0033" ref-type="ref">33</xref> SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>, SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref>, and SLC38A9 <xref rid="feb412219-bib-0034" ref-type="ref">34</xref> are selectively neuronal. Several SLC38 transporters are suggested to participate in the glutamate/GABA&#x02010;glutamine cycle (GGGC), which takes place between neurons and astrocytes <xref rid="feb412219-bib-0011" ref-type="ref">11</xref>, <xref rid="feb412219-bib-0035" ref-type="ref">35</xref>. Glutamate is a potent neurotoxin, and it is vital to have a system for glutamate reuptake, following release by excitatory neurons in the synaptic cleft. Glutamate is produced from glutamine hydrolysis catalyzed by glutaminase in excitatory neurons, and further used as a precursor for GABA in inhibitory neurons <xref rid="feb412219-bib-0036" ref-type="ref">36</xref>. Glutamate released by excitatory neurons is taken up by astrocytes and converted to glutamine, by the enzyme glutamine synthetase. Glutamine is then released from astrocytes and taken up by neurons, completing the cycle <xref rid="feb412219-bib-0037" ref-type="ref">37</xref>. SLC38A1 <xref rid="feb412219-bib-0016" ref-type="ref">16</xref>, <xref rid="feb412219-bib-0038" ref-type="ref">38</xref>, SLC38A2 <xref rid="feb412219-bib-0038" ref-type="ref">38</xref>, SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>, and SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref> are suggested to facilitate the uptake of glutamine in neurons, and SLC38A3 <xref rid="feb412219-bib-0039" ref-type="ref">39</xref> and SLC38A5 <xref rid="feb412219-bib-0040" ref-type="ref">40</xref> the efflux of glutamine from astrocytes.</p><p>In rat, <italic>Slc38a10</italic> mRNA expression was detected throughout the body, with highest relative expression in pituitary, eye, and lung <xref rid="feb412219-bib-0041" ref-type="ref">41</xref>. In another study, where the gene expression of SLCs in rat gastrointestinal (GI) tract was studied, <italic>Slc38a10</italic> and <italic>Slc38a2</italic> were the only SLC38 family members expressed. In addition, they were ubiquitously expressed along the GI tract, suggesting a potential role for SLC38A10 in absorption of amino acids from the GI tract <xref rid="feb412219-bib-0042" ref-type="ref">42</xref>.</p><p>Here, we report bioinformatics data, as well as histological and functional data, of the previously orphan member SLC38A10. We have used pairwise global sequence alignments to determine the sequence identity between the SLC38 family members and predicted the transmembrane helices of SLC38A10. The immunostaining of SLC38A10 was mapped in the mouse brain using nonfluorescent immunohistochemistry and fluorescent immunohistochemistry was used to determine colocalization of SLC38A10 staining with specific cell markers. In addition, <italic>Xenopus&#x000a0;laevis</italic> oocytes were used to overexpress the transporter in order to determine substrate profile for SLC38A10.</p><sec id="feb412219-sec-0002"><title>Materials and methods</title><sec id="feb412219-sec-0003"><title>Predictions of transmembrane helices and global sequence alignments</title><p>The full FASTA human protein sequences for all SLC38 family members were downloaded from the NCBI webpage, [SLC38A1 (NP_001265318.1), SLC38A2 (NP_061849.2), SLC38A3 (NP_006832.1), SLC38A4 (NP_001137296.1), SLC38A5 (NP_277053.2), SLC38A6 (NP_001166173.1), SLC38A7 (NP_060701.1), SLC38A8 (NP_001073911.1), SLC38A9 (NP_775785.2), SLC38A10 (NP_001033073.1), and SLC38A11 (NP_001186077.1)]. The sequence identity was analyzed using EMBOSS Needle global sequence alignment tool (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/psa/emboss_needle/">http://www.ebi.ac.uk/Tools/psa/emboss_needle/</ext-link>). The full protein sequences were pairwise aligned between all members in the family. Furthermore, also the transmembrane helices (TMHs) sequences were pairwise aligned between SLC38A10 and the other family members. The predictions of the TMHs were performed using the <sc>tmhmm server</sc> v.2.0 (<ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/TMHMM/">http://www.cbs.dtu.dk/services/TMHMM/</ext-link>).</p></sec><sec id="feb412219-sec-0004"><title>Ethical statement</title><p>All animal procedures for C57Bl6/J mice (Taconic M&#x00026;B, Lille Skensved, Denmark) and <italic>X.&#x000a0;laevis</italic> frogs (Nasco, Fort Atkinson, WI, USA) were approved by the local ethical committee in Uppsala following the guidelines of the European Communities Council Directive (2010/63), (permit number, mice; C188/12 and frogs; C98/13). Adult male mice were used in all experiments including mice and the animals were kept in a temperature controlled room on a 12&#x02010;h light&#x02013;dark cycle with unlimited access to food, R3 chow (Lantm&#x000e4;nnen, Stockholm, Sweden) and water. Oocyte&#x02010;positive female African claw frogs, <italic>X.&#x000a0;laevis</italic>, were used in all transport experiments including oocytes and the frogs were housed in a temperature controlled room at 21&#x000a0;&#x000b0;C, on a 12&#x02010;h light&#x02013;dark cycle with access to salmon pellets (Aller aqua, Christiansfeld, Denmark).</p></sec><sec id="feb412219-sec-0005"><title>Western blot</title><p>Protein supernatant was extracted from an adult, male C57Bl6/J mouse. In short, crude protein was extracted by homogenizing 0.2&#x000a0;mg brain tissue in 1&#x000a0;mL of lysis buffer [50&#x000a0;m<sc>m</sc> Tris&#x02010;HCl pH 8, 150&#x000a0;m<sc>m</sc> NaCl, 4&#x000a0;m<sc>m</sc> MgCl, 0.5&#x000a0;m<sc>m</sc> EDTA, 2% Triton X&#x02010;100, and 1&#x000a0;m<sc>m</sc> Protease inhibitor PMSF diluted in isopropanol (Sigma&#x02010;Aldrich, St. Louis, MO, USA)]. After a short centrifugation, the supernatant was transferred to a new tube. Subsequently, the homogenate was centrifuged at 10&#x000a0;000 <italic><bold>g</bold></italic> for 10&#x000a0;min receiving pellets and supernatant. Protein concentrations were determined by protein assay DC according to manufacturer's instructions (Bio&#x02010;Rad Laboratories, Hercules, CA, USA). Lammlis loading buffer (Bio&#x02010;Rad Laboratories) and DTT (in a 4&#x000a0;:&#x000a0;1 ratio) were added to protein supernatant samples (60&#x000a0;&#x003bc;g) prior denaturation by heating to 95&#x000a0;&#x000b0;C for 5&#x000a0;min. Samples and PageRuler prestained protein ladder (Fermentas, Burlington, ON, Canada) were separated on a Mini&#x02010;Protean TGX gel (4&#x02013;10%, Bio&#x02010;Rad, Hercules, CA, USA) by gel electrophoresis run at 150V for 30&#x000a0;min in running buffer (0.1% SDS, 0.025&#x000a0;<sc>m</sc> Tris base and 0.192&#x000a0;<sc>m</sc> glycine). The gel was transferred to an Immobilon&#x02010;P polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, USA) and run at 100V for 55&#x000a0;min in transfer buffer (0.025&#x000a0;<sc>m</sc> Tris base, 0.192&#x000a0;<sc>m</sc> glycine and 20% methanol). The membrane was preblocked for 1&#x000a0;h in blocking buffer [5% nonfat dry milk (Bio&#x02010;RAD) diluted in 1.5M NaCl, 0.1M Tris, 0.05% Tween&#x02010;20, pH 8.0 (TTBS)] and then incubated in primary antibody against SLC38A10 (diluted 1&#x000a0;:&#x000a0;800, rabbit&#x02010;anti&#x02010;SLC38A10, synthetic peptide sequence (NH<sub>2</sub>&#x02010;)MTAASTSKWGLIC(&#x02010;CONH<sub>2</sub>), Innovagen, Lund, Sweden) overnight at 4&#x000a0;&#x000b0;C. After washes in TTBS, the membrane was incubated in HRP&#x02010;conjugated secondary antibody (diluted 1&#x000a0;:&#x000a0;10&#x000a0;000, goat&#x02010;anti&#x02010;rabbit, Invitrogen, Waltham, MA, USA) for 1&#x000a0;h, washed again in TTBS followed by detection with the enhanced chemiluminescent (ECL) method and developed on High performance chemiluminescence film (GE healthcare, Chicago, IL, USA).</p></sec><sec id="feb412219-sec-0006"><title>Tissue collection and sectioning</title><p>Mice were anesthetized with an intraperitoneal injection of&#x000a0;sodium pentobarbital (9&#x000a0;mg&#x000b7;kg<sup>&#x02212;1</sup> IP; Apoteksbolaget, Stockholm, Sweden). Transcardial perfusion was performed through the left ventricle with phosphate&#x02010;buffered saline (PBS) followed by 4% formaldehyde (HistoLab, Gothenburg, Sweden) fixation. Brain and spinal cord tissues were surgically removed and stored in 4% formaldehyde overnight. For free&#x02010;floating brain tissue sections, the tissue was washed in PBS, embedded in 4% agarose and sections were cut at 70&#x000a0;&#x003bc;m by using a vibratome (Leica VT1000S Microsystems, Wetzlar, Germany) in PBS. For paraffin embedding, tissues were fixed in zinc&#x02010;formalin (Thermo Fisher, Waltham, MA, USA), dehydrated, and paraffin infused (Tissue&#x02010;Tek vacuum infiltration processor, Sakura, the Netherlands). Paraffin sections of 7&#x000a0;&#x003bc;m were cut using a Microm 355S STS cool cut microtome (Thermo Fisher).</p></sec><sec id="feb412219-sec-0007"><title>Nonfluorescent immunohistochemistry on free&#x02010;floating sections</title><p>Single immunohistochemistry (IHC) was performed with the primary SLC38A10 antibody (diluted 1&#x000a0;:&#x000a0;200, rabbit&#x02010;anti&#x02010;SLC38A10, Innovagen) and a biotinylated secondary antibody (diluted 1&#x000a0;:&#x000a0;400, goat&#x02010;anti&#x02010;rabbit, Vector Laboratories, Burlingame, CA, USA) as previously described <xref rid="feb412219-bib-0043" ref-type="ref">43</xref>.</p></sec><sec id="feb412219-sec-0008"><title>Fluorescent immunohistochemistry on paraffin&#x02010;embedded sections</title><p>Fluorescent IHC was performed on paraffin&#x02010;embedded mouse brain sections according to H&#x000e4;gglund <italic>et&#x000a0;al</italic>. <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>, with the following changes. The primary SLC38A10 antibody was combined with antibody markers detecting NeuN, pan Neuronal, MAP2, GAD67, GFAP, pan Cytokeratin, and Synaptophysin overnight at 4&#x000a0;&#x000b0;C. For antibody information see Table&#x000a0;<xref rid="feb412219-tbl-0001" ref-type="table-wrap">1</xref>. Fluorescent staining was analyzed using a fluorescent microscope (Zeiss Axioplan2 imaging) connected to a camera (AxioCam HRm) with the <sc>axiovison</sc> 4.7 software.</p><table-wrap id="feb412219-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Details of antibodies used for fluorescent immunohistochemistry</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Species</th><th align="left" valign="top" rowspan="1" colspan="1">Dilution</th><th align="left" valign="top" rowspan="1" colspan="1">Company</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Primary antibodies</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;SLC38A10</td><td align="left" rowspan="1" colspan="1">Rabbit</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Innovagen, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;NeuN</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Millipore, Solna, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;Pan Neuronal</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;100</td><td align="left" rowspan="1" colspan="1">Millipore, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;MAP2</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;500</td><td align="left" rowspan="1" colspan="1">Sigma, Malm&#x000f6;, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;Gad67</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;200</td><td align="left" rowspan="1" colspan="1">Millipore, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;GFAP</td><td align="left" rowspan="1" colspan="1">Chicken</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Abcam, Cambridge, UK</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;Pan Cytokeratin</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;200</td><td align="left" rowspan="1" colspan="1">Sigma, Sweden</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;Synaptophysin</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;200</td><td align="left" rowspan="1" colspan="1">BD Transduction Laboratories, Stockholm, Sweden</td></tr><tr><td align="left" colspan="4" rowspan="1">Secondary antibodies</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;rabbit&#x02010;594</td><td align="left" rowspan="1" colspan="1">Donkey</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Invitrogen, USA</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;mouse&#x02010;488</td><td align="left" rowspan="1" colspan="1">Goat</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Invitrogen, USA</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anti&#x02010;chicken&#x02010;488</td><td align="left" rowspan="1" colspan="1">Goat</td><td align="left" rowspan="1" colspan="1">1&#x000a0;:&#x000a0;400</td><td align="left" rowspan="1" colspan="1">Invitrogen, USA</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="feb412219-sec-0009"><title>Cloning of Slc38a10 and cRNA synthesis for oocyte microinjections</title><p>The mouse <italic>Slc38a10</italic> clone (6493546) was purchased from Invitrogen. <italic>Slc38a10</italic> was amplified using the forward (GATCGAATTCACAGCCACCGGAATGACGGCCGCCTCCACCTCC) and reverse (GATCGCGGCCGCTCAGGCTTCCTCCAGATCTCCAG) primers and Platinum proofreading DNA polymerase (Invitrogen) according to standard PCR procedures. <italic>Slc38a10</italic> was cloned using the TOPO<sup>&#x000ae;</sup>&#x02010;TA cloning kit (Invitrogen) following the manufacturers protocol. <italic>Slc38a10</italic> was again linearized and amplified using the forward reverse primers, previous listed. The oocyte vector p&#x003b2;GFP/RN3P and the <italic>Slc38a10</italic> PCR product were cut using the enzymes EcoRI and NotI (Fermentas) and ligated together using T4 ligase (Invitrogen). Heat chock transformation of the p&#x003b2;GFP/RN3P/<italic>Slc38a10</italic> construct was performed followed by colony PCR using T7 and T3 primers. Plasmid cDNA was prepared with the JET star 2.0 Plasmid Purification Midi kit/50 (Genomed, Germany) and the concentration was measured with Nanodrop<sup>&#x000ae;</sup> ND&#x02010;1000 Spectrophotometer (Nanodrop technologies, Wilmington, DE, USA). The clone was sequenced (Eurofins MWG Operon, Ebersberg, Germany) and verified correct. The <italic>Slc38a10</italic> cRNA was synthesized by digesting the p&#x003b2;GFP/RN3P/<italic>Slc38a10</italic> vector with SfiI (Fermentas). The mMessage mMachine<sup>&#x000ae;</sup> T3 transcription kit (Thermo Fisher) and the PCR purification kit (Qiagen, Venlo, the Netherlands) were used for capped RNA transcription and purification following the manufacturer's protocol. The cRNA concentration was measured and controlled using the Experion RNA Std&#x02010;Sens Analysis kit with an Experion automated electrophoresis system (Bio&#x02010;Rad). The cRNA was stored at &#x02212;80&#x000a0;&#x000b0;C.</p></sec><sec id="feb412219-sec-0010"><title>Oocyte preparation and oocyte microinjections</title><p>
<italic>Xenopus laevis</italic> frogs were anesthetized using a 2.5&#x000a0;g&#x000b7;L<sup>&#x02212;1</sup> MS222 [Ethyl 3&#x02010;aminobenzoate methanesulfonate salt, (Sigma&#x02010;Aldrich)] bath buffered with NaHPO<sub>4</sub> (Sigma&#x02010;Aldrich) to pH 7 for 10&#x02013;15&#x000a0;min. Oocytes were harvested from ventrum and treated with seven units of Liberase&#x02122; (Roche Diagnostics, Basel, Switzerland) for 2&#x000a0;h at 19&#x000a0;&#x000b0;C, rotating 90&#x000b0; 2&#x000a0;rpm. Stage V and VI oocytes were used for experiments and oocytes were injected with 23&#x000a0;nL <italic>Slc38a10</italic> cRNA (15&#x02013;23&#x000a0;ng) using the Nanoject II autonanoliter injector (Drummond Scientific, USA). The injected and noninjected control oocytes were incubated in OR2 buffer (82.0&#x000a0;m<sc>m</sc> NaCl, 2.5&#x000a0;m<sc>m</sc> KCl, 1.0&#x000a0;m<sc>m</sc> CaCl<sub>2</sub>, 1.0&#x000a0;m<sc>m</sc> MgCl<sub>2</sub>, 1.0&#x000a0;m<sc>m</sc> Na<sub>2</sub>HPO<sub>4</sub>, and 5.0&#x000a0;m<sc>m</sc> HEPES, pH 7.8) supplemented with 67&#x000a0;&#x003bc;g&#x000b7;mL<sup>&#x02212;1</sup> tetracycline hydrochloride (MP Biomedicals, Santa Ana, CA, USA) for 2&#x02013;4&#x000a0;days at 19&#x000a0;&#x000b0;C prior experiments.</p></sec><sec id="feb412219-sec-0011"><title>Radiolabeled uptake assays</title><p>Radiolabeled uptakes assays were performed as previously described in <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>. Briefly, oocytes were incubated in KRH transport buffer (118.0&#x000a0;m<sc>m</sc> NaCl, 4.8&#x000a0;m<sc>m</sc> KCl, 2.5&#x000a0;m<sc>m</sc> CaCl<sub>2</sub>, 10.0&#x000a0;m<sc>m</sc> Hepes, pH 7.8) for 15&#x000a0;min prior to incubation in 100&#x000a0;&#x003bc;L of radiolabeled amino acid (0.2&#x000a0;&#x003bc;<sc>m</sc> labeled and 1.0&#x000a0;&#x003bc;<sc>m</sc> nonlabeled <sc>l</sc>&#x02010;amino acid in KRH, for <sc>d</sc>&#x02010;Asp; 0.2&#x000a0;&#x003bc;<sc>m</sc> [<sup>3</sup>H]&#x02010;<sc>d</sc>&#x02010;Asp and 1.0&#x000a0;&#x003bc;<sc>m</sc> nonlabeled <sc>l</sc>&#x02010;Asp was used) for 50&#x000a0;min or every 5&#x000a0;min for 60&#x000a0;min in 96&#x02010;well BRANDplates<sup>&#x000ae;</sup> pureGrade&#x02122; (BRAND GMBH, Wertheim, Germany). Then 100&#x000a0;&#x003bc;L of ice cold KRH buffer was added to stop the uptake and the oocytes were washed twice in 200&#x000a0;&#x003bc;L of ice cold KRH buffer. Oocytes were lysed in 100&#x000a0;&#x003bc;L 10% SDS and transferred to scintillation tubes Minis 2000 (Zinsser analytic, Frankfurt, Germany) with 2.5&#x000a0;mL Aquasafe 300 plus scintillation liquid (Zinsser analytic). The uptake was measured in counts per minute (cpm) using the liquid scintillation analyzer, Tri&#x02010;Carb<sup>&#x000ae;</sup> 2910 TR (Perkin Elmer, Waltham, MA, USA). Uptake experiments were performed with <italic>n</italic>&#x000a0;=&#x000a0;5&#x02013;12 oocytes in each group, (SLC38A10 overexpressing oocytes and control oocytes) and outliers were removed using Grubbs test. All amino acids used were labeled with [<sup>3</sup>H], and MeAIB was [<sup>14</sup>C] labeled, all purchased from Perkin Elmer with specific activity, <sc>l</sc>&#x02010;Ala 83.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Arg 43.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>d</sc>&#x02010;Asp 12.9 Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Glu 51.1 Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Gln 50.3 Ci&#x000b7;mmol<sup>&#x02212;1</sup>, Gly 52.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Leu 56.2&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Lys 97.3 Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Met 81.0 Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Pro 75.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Ser 15.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, <sc>l</sc>&#x02010;Tyr 40.0&#x000a0;Ci&#x000b7;mmol<sup>&#x02212;1</sup>, and MeAIB 58.7&#x000a0;mCi&#x000b7;mmol<sup>&#x02212;1</sup>. All nonlabeled amino acids were purchased from Sigma&#x02010;Aldrich.</p></sec><sec id="feb412219-sec-0012"><title>Radiolabeled efflux assays</title><p>Fourteen oocytes (seven SLC38A10 and seven control oocytes) were injected with 23&#x000a0;nL [<sup>3</sup>H]&#x02010;labeled amino acid and incubated in ice cold ND96 transport buffer (96.0&#x000a0;m<sc>m</sc> NaCl, 2.0&#x000a0;m<sc>m</sc> KCl, 1.8&#x000a0;m<sc>m</sc> CaCl<sub>2</sub>, 1.0&#x000a0;m<sc>m</sc> MgCl<sub>2</sub>, 5.0&#x000a0;m<sc>m</sc> Hepes, pH 7.8 or pH7.4) for 15&#x000a0;min on ice followed by two washes in 2&#x000a0;mL ice cold ND96 buffer in 24&#x02010;well tissue culture plates (VWR, Radnor, PA, USA). The oocytes were incubated in 1&#x000a0;mL RT ND96 buffer and 100&#x000a0;&#x003bc;L of buffer was extracted from the supernatant in each well every 5&#x000a0;min for 30&#x000a0;min and transferred to scintillation tubes Minis 2000 (Zinsser analytic) with 2.5&#x000a0;mL Aquasafe 300 plus scintillation liquid (Zinsser analytic). The efflux was measured in cpm with the liquid scintillation analyzer, Tri&#x02010;Carb<sup>&#x000ae;</sup> 2910 TR (Perkin Elmer). The oocyte and the remaining 400&#x000a0;&#x003bc;L ND96 buffer in each well after the time course efflux experiment was also analyzed using scintillation counting to facilitate discovering of outliers, either by failed amino acid injection or leaking oocytes. Outliers were removed with Grubbs test after evaluation of the measured cpm in the oocyte and the remaining buffer following the efflux assay. Each analyzed experiment presented has <italic>n</italic>&#x000a0;=&#x000a0;5&#x02013;7 oocytes in each treatment group.</p></sec><sec id="feb412219-sec-0013"><title>Statistical analysis</title><p>All graphs and statistical analysis were performed using the software <sc>graphpad prism</sc> 5. Unpaired t&#x02010;tests with 95% confidence interval was performed between oocytes overexpressing SLC38A10 and control oocytes, (*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, ***<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.001).</p></sec></sec><sec id="feb412219-sec-0014"><title>Results</title><sec id="feb412219-sec-0015"><title>Prediction of transmembrane helices for SLC38A10</title><p>The human SLC38A10 protein sequence was analyzed to predict the transmembrane helices (TMHs) of the protein. According to the TMHMM Server v.2.0, nine helices (I&#x02013;V, VII, and IX&#x02013;XI), that fulfill the criteria's to be TMHs were found, and additional two (VI and VIII) TMHs was manually identified by the highest score of membrane localization. This analysis revealed that SLC38A10 has an intracellular N&#x02010;terminal and a long C&#x02010;terminal of 722 amino acids (amino acid 398&#x02013;1019) on the outside of the membrane. A model of the predicted transmembrane folding of the SLC38A10 protein sequence with 11 TMHs is presented in Fig.&#x000a0;<xref rid="feb412219-fig-0001" ref-type="fig">1</xref>.</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Predicted transmembrane folding of <styled-content style="fixed-case">SLC</styled-content>38A10. The transmembrane helices were predicted for the human <styled-content style="fixed-case">SLC</styled-content>38A10 protein sequences. Eleven <styled-content style="fixed-case">TMH</styled-content>s were identified (I&#x02010;<styled-content style="fixed-case">XI</styled-content>). The circles represent each amino acid (<styled-content style="fixed-case">AA</styled-content>) in the protein sequence and the last 398&#x02013;1119 amino acids are not specified. <styled-content style="fixed-case">SLC</styled-content>38A10 was found to have an intracellular N&#x02010;terminal and a long C&#x02010;terminal of 722 amino acids outside the membrane.</p></caption><graphic id="nlm-graphic-3" xlink:href="FEB4-7-730-g001"/></fig></sec><sec id="feb412219-sec-0016"><title>Matrix of global sequence alignments for the SLC38 family</title><p>The full human protein sequences for the SLC38 family members were pairwise aligned using EMBOSS Needle global sequence alignment tool. The complete protein sequences were pairwise aligned between all SLC38 family members and the sequence identity between the members is presented in percent (%) (Fig.&#x000a0;<xref rid="feb412219-fig-0002" ref-type="fig">2</xref>A). Overall, this analysis displays that SLC38A1&#x02010;A6 have high sequence identity ranging from 34&#x02013;58%, while only some of these members share approximately 20% sequence identity with SLC38A7, SLC38A8, and SLC38A11. However, SLC38A7 and SLC38A8 share 37% sequence identity. Moreover, this analysis displays that both SLC38A9 and SLC38A10 have less than 20% sequence identity with the other family members. For SLC38A10, the sequence identity is less than 10% with all other family members, and hence, it does not fulfill the criteria (&#x0003e;20%) for being a SLC38 family member. The protein sequence of SLC38A10 is more than twice as long as the other members of the SLC38 family, with a long C&#x02010;terminal tail without homology to any other member of the family. Therefore, the global sequence alignment was performed again, with only the protein sequence from start of TMH 1 until end of TMH 11 was used (Fig.&#x000a0;<xref rid="feb412219-fig-0002" ref-type="fig">2</xref>B). This analysis showed that SLC38A10 share more than 20% sequence identity with all members except for SLC38A6 and SLC38A9, with highest sequence identity to SLC38A2 (24.7%). In general, this analysis displays that SLC38A10 share sequence identity within the range of 21.9&#x02013;24.7% with all the other family members.</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Sequence identity matrixes of the <styled-content style="fixed-case">SLC</styled-content>38 family members. <styled-content style="fixed-case">EMBOSS</styled-content> global sequence alignment tool was used to align the human protein sequences for the <styled-content style="fixed-case">SLC</styled-content>38 family members. (A) The 12&#x000a0;&#x000d7;&#x000a0;12 matrix display the sequence identity in % between all members in the family. The full human protein sequence for all members was used. <styled-content style="fixed-case">SLC</styled-content>38A10 had low sequence identity, &#x0003c;10%, with the other members, because of the length of the protein sequence, which is approximately twice as long as for the other members. (B) The amino acids from the first to the last transmembrane helices were identified for all members, and pairwise aligned with the transmembrane sequence for <styled-content style="fixed-case">SLC</styled-content>38A10. This matrix shows that <styled-content style="fixed-case">SLC</styled-content>38A10 share high transmembrane sequence identity with most of the members in the <styled-content style="fixed-case">SLC</styled-content>38 family. <styled-content style="fixed-case">SLC</styled-content>38A10 shares more than 20% sequence identity with all members in the family, except with <styled-content style="fixed-case">SLC</styled-content>38A6 and <styled-content style="fixed-case">SLC</styled-content>38A9.</p></caption><graphic id="nlm-graphic-5" xlink:href="FEB4-7-730-g002"/></fig></sec><sec id="feb412219-sec-0017"><title>Western blot to verify the custom&#x02010;made anti&#x02010;SLC38A10 antibody</title><p>We generated a rabbit polyclonal anti&#x02010;SLC38A10 antibody. The specificity of the custom&#x02010;made antibody was verified using western blot analysis (Fig.&#x000a0;<xref rid="feb412219-fig-0003" ref-type="fig">3</xref>). The theoretical size of the SLC38A10 protein in mouse is 116.3&#x000a0;kDa (AAH82300.1, 1081 amino acids). The western blot detected a strong band at approximately 110&#x000a0;kDa, suggesting epitope&#x02010;specific binding of the antibody to the SLC38A10 protein.</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Verification of the anti&#x02010;<styled-content style="fixed-case">SLC</styled-content>38A10 antibody specificity. Characterization of the custom&#x02010;made polyclonal <styled-content style="fixed-case">SLC</styled-content>38A10 antibody was performed with western blot. The western blot shows a supernatant (60&#x000a0;&#x003bc;g) crude lysate fraction and the ladder in <styled-content style="fixed-case">kD</styled-content>a. One strong band was detected at ~110&#x000a0;kDa, suggesting specificity of the custom&#x02010;made polyclonal <styled-content style="fixed-case">SLC</styled-content>38A10 antibody.</p></caption><graphic id="nlm-graphic-7" xlink:href="FEB4-7-730-g003"/></fig></sec><sec id="feb412219-sec-0018"><title>Abundant immunostaining of SLC38A10 in mouse brain</title><p>A screen of the mouse brain was performed using nonfluorescent immunohistochemistry on free&#x02010;floating mouse brain sections, see Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>. Extensive immunoreactivity of the transporter was detected in striatum, in ependyma, and cells close to the ventricles, cerebral cortex, hippocampus, hypothalamus, thalamus, pons, and cerebellum. Furthermore, SLC38A10 immunoreactivity was seen in accumbens nucleus (Acb) and piriform cortex (pir) (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>A and G). High immunostaining of SLC38A10 was located to cells within dorsal 3rd ventricle (D3V) and lateral ventricle (LV), possible choroid plexus (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>B and H). Hypothalamic staining of SLC38A10 was visualized in paraventricular hypothalamic area (Pa), suprachiasmatic nucleus (SCh) and in anterior hypothalamic area, central (AHC) (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>C and I). Additional hypothalamic staining was in dorsomedial hypothalamic nucleus (DM), arcuate nucleus (Arc), and in ventromedial hypothalamic nucleus (VMH) (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>D and J). SLC38A10 immunostaining was located to cells scattered throughout the cerebral cortex and in the pyramidal cell layer (Py) of the hippocampus (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>D and K). In the midbrain, SLC38A10 localized to ventral tegmental area (VTA) and dentate gyrus (DG) (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>E and L). In cerebellum SLC38A10 staining was detected in the Purkinje layer (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>F and M), and in pons, in locus coeruleus (LC) and Barringtons nucleus (Bar) close to the 4th ventricle (4V) (Fig.&#x000a0;<xref rid="feb412219-fig-0004" ref-type="fig">4</xref>F and N).</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 in the mouse brain. Nonfluorescent immunohistochemistry on free&#x02010;floating sections with overview pictures (A&#x02013;F) and close up pictures (G&#x02013;N) of <styled-content style="fixed-case">SLC</styled-content>38A10 immunostaining in mouse brain. (G) Staining of <styled-content style="fixed-case">SLC</styled-content>38A10 in nucleus accumbens (Acb), caudate putamen (<styled-content style="fixed-case">CP</styled-content>u, striatum) and in piriform cortex (Pir) (Bregma 1.54). (H) <styled-content style="fixed-case">SLC</styled-content>38A10 immunoreactivity in cells within D3V and <styled-content style="fixed-case">LV</styled-content> (Bregma &#x02212;0.82). (I) High immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 in paraventricular hypothalamic nucleus (Pa), suprachiasmatic nucleus (<styled-content style="fixed-case">SC</styled-content>h) and in anterior hypothalamic area central part (<styled-content style="fixed-case">AHC</styled-content>) close to the 3V (Bregma &#x02212;0.94). (J) Localization of <styled-content style="fixed-case">SLC</styled-content>38A10 in dorsomedial hypothalamic nucleus (<styled-content style="fixed-case">DM</styled-content>), arcuate hypothalamic nucleus (Arc), and in ventromedial hypothalamic nucleus (<styled-content style="fixed-case">VMH</styled-content>) (Bregma &#x02212;1.58). (K) Scattered <styled-content style="fixed-case">SLC</styled-content>38A10 staining in cells throughout cerebral cortex (Bregma &#x02212;1.58). (L) Immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 in ventral tegmental area (<styled-content style="fixed-case">VTA</styled-content>), dentate gyrus (<styled-content style="fixed-case">DG</styled-content>), and in pyramidal cell layer of the hippocampus (Py) (Bregma &#x02212;3.08). (M) <styled-content style="fixed-case">SLC</styled-content>38A10 immunoreactivity in the Purkinje layer of cells in cerebellum (Bregma &#x02212;5.52). (N) Immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 in locus coeruleus (<styled-content style="fixed-case">LC</styled-content>) and Barrington's nucleus (Bar) in pons close to the 4V. Additional abbreviations: endopiriform claustrum (En), accumbens nucleus core (AcbC), accumbens nucleus shell (AcbSh), corpus callosum (cc), habenular nucleus (Hb), stria medullaris (sm), anterodorsal thalamic nucleus (<styled-content style="fixed-case">AD</styled-content>), ventromedial hypothalamic nucleus central part (<styled-content style="fixed-case">VMHC</styled-content>), ventromedial hypothalamic nucleus dorsomedial part (<styled-content style="fixed-case">VMHDM</styled-content>), ventromedial hypothalamic nucleus ventrolateral part (<styled-content style="fixed-case">VMHVL</styled-content>), primary somatosensory cortex trunk region (S1Tr), external capsule (ec), interpeduncular fossa (<styled-content style="fixed-case">IPF</styled-content>), parabrachial pigmented nucleus of the <styled-content style="fixed-case">VTA</styled-content> (<styled-content style="fixed-case">PBP</styled-content>), substantia nigra reticular part (<styled-content style="fixed-case">SNR</styled-content>), primary fissure (prf), simple lobule (Sim), superior cerebellar peduncle (scp), medial parabrachial nucleus (<styled-content style="fixed-case">MPB</styled-content>), laterodorsal tegmental nucleus (<styled-content style="fixed-case">LDT</styled-content>g), and facial nerve (7n). The described brain regions were depicted using, The Mouse Brain, by Franklin and Paxinos 2007.</p></caption><graphic id="nlm-graphic-9" xlink:href="FEB4-7-730-g004"/></fig></sec><sec id="feb412219-sec-0019"><title>Neuronal, astrocytic, and epithelial localization of SLC38A10 in mouse CNS</title><p>Fluorescent immunohistochemistry was used to study colocalization of SLC38A10 immunoreactivity with antibody markers to pinpoint the type of cells expressing the transporter on paraffin&#x02010;embedded mouse brain and spinal cord sections (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>). A number of neuronal markers were used and overlapping staining was detected with the marker of neuron&#x02010;specific nuclear proteins of most neuronal cell types NeuN <xref rid="feb412219-bib-0044" ref-type="ref">44</xref> in the CA fields of hippocampus in brain (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>A). The SLC38A10 immunostaining also colocalized with the neuronal cell marker pan Neuronal <xref rid="feb412219-bib-0045" ref-type="ref">45</xref> in cerebral cortex in brain (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>B), and with the neuron&#x02010;specific cytoskeletal protein marker microtubule associated protein 2 (MAP2) <xref rid="feb412219-bib-0046" ref-type="ref">46</xref> in large motor neurons and interneurons in the spinal cord (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>C). Moreover, the Gad67 marker was used for staining GABAergic neurons <xref rid="feb412219-bib-0047" ref-type="ref">47</xref> and the immunoreactivity of SLC38A10 and Gad67 colocalized in inhibitory neurons in cerebral cortex in brain (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>D). Staining also colocalized in astrocytes, visualized with overlapping staining between the astrocyte marker glial fibrillary acidic protein (GFAP) <xref rid="feb412219-bib-0048" ref-type="ref">48</xref> and SLC38A10 in hypothalamus close to the third ventricle (3V) in brain (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>E). In addition, SLC38A10 immunoreactivity was detected in cells with positive staining of the choroid plexus epithelial cell marker pan Cytokeratin <xref rid="feb412219-bib-0049" ref-type="ref">49</xref> in cells surrounding the lateral ventricle (LV) in brain (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>F). The lack of colocalization between SLC38A10 and the vesicular marker Synaptophysin <xref rid="feb412219-bib-0050" ref-type="ref">50</xref> suggests that SLC38A10 does not overlap with vesicles in nerve terminals in grey matter in the spinal cord (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>G). Taken together, SLC38A10 staining was located to neurons, astrocytes, and epithelial cells in mouse CNS.</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 in neurons and astrocytes. Fluorescent immunohistochemistry on mouse brain and spinal cord sections with <styled-content style="fixed-case">SLC</styled-content>38A10 immunoreactivity (red), protein markers (green), and nucleus marker <styled-content style="fixed-case">DAPI</styled-content> (blue). (A) The neuronal marker NeuN co&#x02010;localized with <styled-content style="fixed-case">SLC</styled-content>38A10 in hippocampus in brain (Bregma &#x02212;2.06). (B) Overlapping staining between <styled-content style="fixed-case">SLC</styled-content>38A10 and pan Neuronal in cortex in brain (Bregma 0.14). (C) The immunostaining of <styled-content style="fixed-case">SLC</styled-content>38A10 and the neuronal marker <styled-content style="fixed-case">MAP</styled-content>2 was overlapping in motor neurons in&#x000a0;spinal cord (upper vertebrae L2 lumbar). (D) The <styled-content style="fixed-case">SLC</styled-content>38A10 staining colocalized with cells labeled with the <styled-content style="fixed-case">GABA</styled-content>ergic marker Gad67 in&#x000a0;cortex in brain (Bregma 0.26). (E) Highly overlapping immunostaining between <styled-content style="fixed-case">SLC</styled-content>38A10 and the astrocyte marker <styled-content style="fixed-case">GFAP</styled-content> in hypothalamus close to 3V in brain (Bregma 0.26). (F) Co&#x02010;localization of <styled-content style="fixed-case">SLC</styled-content>38A10 and pan Cytokeratin in cells surrounding the <styled-content style="fixed-case">LV</styled-content> in brain (Bregma &#x02212;0.10). (G) No overlap between <styled-content style="fixed-case">SLC</styled-content>38A10 and the synapse marker Synaptophysin in spinal cord (upper vertebrae L2 lumbar). Yellow arrows indicate cells expressing the <styled-content style="fixed-case">SLC</styled-content>38A10 protein and white arrows indicate cells expressing the marker. Scale bars 20&#x000a0;&#x003bc;m.</p></caption><graphic id="nlm-graphic-11" xlink:href="FEB4-7-730-g005"/></fig></sec><sec id="feb412219-sec-0020"><title>SLC38A10 transports <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;glutamate, <sc>d</sc>&#x02010;aspartate, and MeAIB</title><p>To determine the substrate profile for SLC38A10 we used <italic>X. laevis</italic> oocytes to overexpress the transporter, and performed radiolabeled uptake assays (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>). This is a commonly used expression system for membrane&#x02010;bound transporters <xref rid="feb412219-bib-0021" ref-type="ref">21</xref>, <xref rid="feb412219-bib-0051" ref-type="ref">51</xref>. The uptake of <sc>l</sc>&#x02010;glutamine was measured every five min for 60&#x000a0;min and the oocytes were incubated in 0.2&#x000a0;&#x003bc;<sc>m</sc> [<sup>3</sup>H]&#x02010;<sc>l</sc>&#x02010;Gln and 1&#x000a0;&#x003bc;<sc>m</sc> nonlabeled <sc>l</sc>&#x02010;Gln in KRH buffer. The SLC38A10 overexpressing oocytes displayed significant uptake of <sc>l</sc>&#x02010;glutamine early, between 5&#x02013;30&#x000a0;min while significantly higher uptake was measured in the controls at 45&#x02013;55&#x000a0;min compared with SLC38A10 oocytes (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>A). Oocytes were incubated in KRH buffer with radiolabeled 0.2&#x000a0;&#x003bc;<sc>m</sc> [<sup>3</sup>H]&#x02010;<sc>l</sc>&#x02010;amino acid and 1&#x000a0;&#x003bc;<sc>m</sc> nonlabeled <sc>l</sc>&#x02010;amino acid for 50&#x000a0;min, and the uptake was measured. The uptake assay of 11 amino acids resulted in significantly higher uptake of <sc>l</sc>&#x02010;glutamine and <sc>l</sc>&#x02010;glutamate in controls compared with SLC38A10 oocytes while significant uptake of <sc>l</sc>&#x02010;alanine was measured in SLC38A10 oocytes compared with controls. There was no significant uptake of <sc>l</sc>&#x02010;serine, <sc>l</sc>&#x02010;proline, glycine, <sc>l</sc>&#x02010;methionine, <sc>l</sc>&#x02010;tyrosine, <sc>l</sc>&#x02010;arginine, <sc>l</sc>&#x02010;leucine, or <sc>l</sc>&#x02010;lysine (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>B). The uptake of <sc>d</sc>&#x02010;aspartate was measured at 50&#x000a0;min in competition with <sc>l</sc>&#x02010;aspartate (0.2&#x000a0;&#x003bc;<sc>m</sc> [<sup>3</sup>H]&#x02010;<sc>d</sc>&#x02010;Asp and 1&#x000a0;&#x003bc;<sc>m</sc> nonlabeled <sc>l</sc>&#x02010;Asp in KRH buffer). The uptake was measured in different batches of oocytes. Using the first batch (Batch 1) of oocytes significantly higher uptake of <sc>d</sc>&#x02010;aspartate was observed in controls, while the second batch (Batch 2) of oocytes resulted in significantly higher uptake of <sc>d</sc>&#x02010;aspartate in SLC38A10 oocytes compared with controls (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>C). An additional uptake assay using [<sup>3</sup>H]&#x02010;<sc>l</sc>&#x02010;Glu was run at 50&#x000a0;min which resulted in significant uptake of <sc>l</sc>&#x02010;glutamate in SLC38A10 oocytes (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>D). The synthetic amino acid analog MeAIB was significantly taken up by oocytes expression SLC38A10 (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>E).</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Transport data from radiolabeled uptake assays. The uptake of 0.2&#x000a0;&#x003bc;<sc>m</sc> radiolabeled substrate in <styled-content style="fixed-case">SLC</styled-content>38A10 overexpressing oocytes compared with control oocytes was measured in counts per minute (cpm) using scintillation counting. Unpaired t&#x02010;test with 95% confidence interval was performed, (*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, ***<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.001), (<italic>n</italic>&#x000a0;=&#x000a0;number of <styled-content style="fixed-case">SLC</styled-content>38A10 overexpressing oocytes; number of control oocytes). (A) Uptake of <sc>l</sc>&#x02010;glutamine was measured every 5&#x000a0;min for 60&#x000a0;min, (measured uptake&#x000a0;&#x000b1;&#x000a0;<styled-content style="fixed-case">SD</styled-content>), [(5&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0222), (10&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;7;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0197), (15&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0405), (20&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;7;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0504), (25&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;7, <italic>P</italic>&#x000a0;=&#x000a0;0.2676), (30&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0328), (35&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.1007), (40&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.4081), (45&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (50&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (55&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.0217), (60&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;8;8, <italic>P</italic>&#x000a0;=&#x000a0;0.8633)]. Uptake of <sc>l</sc>&#x02010;glutamine by <styled-content style="fixed-case">SLC</styled-content>38A10 overexpressing oocytes was measured initially (5&#x02013;30&#x000a0;min) while higher uptake was measured in controls later at 45&#x02013;55&#x000a0;min. (B) Uptake assay screen of 11 amino acids with 50&#x000a0;min incubation time, (measured uptake&#x000a0;&#x000b1;&#x000a0;<styled-content style="fixed-case">SD</styled-content>), [Gln (<sc>l</sc>&#x02010;glutamine) <italic>n</italic>&#x000a0;=&#x000a0;11;12, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001], [Glu (<sc>l</sc>&#x02010;glutamatic acid), <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001], [Ala (<sc>l</sc>&#x02010;alanine), <italic>n</italic>&#x000a0;=&#x000a0;5;6, <italic>P</italic>&#x000a0;=&#x000a0;0.0273], [Ser (<sc>l</sc>&#x02010;serine), <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.0551], [Pro (<sc>l</sc>&#x02010;proline), <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.3030], [Gly (glycine), <italic>n</italic>&#x000a0;=&#x000a0;6;5, <italic>P</italic>&#x000a0;=&#x000a0;0.1520], [Met (<sc>l</sc>&#x02010;methionine), <italic>n</italic>&#x000a0;=&#x000a0;5;6, <italic>P</italic>&#x000a0;=&#x000a0;0.7039], [Tyr (<sc>l</sc>&#x02010;tyrosine), <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.4203], [Arg (<sc>l</sc>&#x02010;arginine), <italic>n</italic>&#x000a0;=&#x000a0;6;5, <italic>P</italic>&#x000a0;=&#x000a0;0.6040], [Leu (<sc>l</sc>&#x02010;leucine), <italic>n</italic>&#x000a0;=&#x000a0;6;5, <italic>P</italic>&#x000a0;=&#x000a0;0.3547] and [Lys (<sc>l</sc>&#x02010;lysine), <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.1310]. (C) Competition uptake assay of <sc>d</sc>&#x02010;aspartate using two different batches of oocytes with 50&#x000a0;min incubation time, (measured uptake &#x000b1;<styled-content style="fixed-case">SD</styled-content>), Batch 1, <italic>n</italic>&#x000a0;=&#x000a0;7;8, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001, Batch 2, <italic>n</italic>&#x000a0;=&#x000a0;11;12, <italic>P</italic>&#x000a0;=&#x000a0;0.0170. (D) Additional uptake assay of <sc>l</sc>&#x02010;glutamate with 50&#x000a0;min incubation time, (measured uptake &#x000b1;<styled-content style="fixed-case">SD</styled-content>), (<sc>l</sc>&#x02010;Glu, <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.0045). (E) Uptake of Me<styled-content style="fixed-case">AIB</styled-content> with 50&#x000a0;min incubation time, (measured uptake&#x000b1;<styled-content style="fixed-case">SD</styled-content>), <italic>n</italic>&#x000a0;=&#x000a0;8;11, <italic>P</italic>&#x000a0;=&#x000a0;0.0002.</p></caption><graphic id="nlm-graphic-13" xlink:href="FEB4-7-730-g006"/></fig></sec><sec id="feb412219-sec-0021"><title>Efflux of <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;glutamate, <sc>d</sc>&#x02010;aspartate, and <sc>l</sc>&#x02010;serine by SLC38A10</title><p>Since both higher and lower uptake was measured for several amino acids in SLC38A10 oocytes compared with controls, efflux assays was performed by injecting oocytes with 23&#x000a0;nL radiolabeled amino acid. The efflux was measured in 100&#x000a0;&#x003bc;L of ND96 transport buffer every 5&#x000a0;min for 30&#x000a0;min (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>). The efflux assay resulted in significant efflux of <sc>l</sc>&#x02010;glutamine (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>A), <sc>l</sc>&#x02010;glutamate (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>B), <sc>l</sc>&#x02010;alanine (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>C), <sc>l</sc>&#x02010;serine (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>D), and <sc>d</sc>&#x02010;aspartate (Fig.&#x000a0;<xref rid="feb412219-fig-0007" ref-type="fig">7</xref>E). No significant efflux was measured for <sc>l</sc>&#x02010;proline, glycine, <sc>l</sc>&#x02010;methionine, <sc>l</sc>&#x02010;tyrosine, <sc>l</sc>&#x02010;arginine, <sc>l</sc>&#x02010;leucine, or <sc>l</sc>&#x02010;lysine (data not shown).</p><fig fig-type="Figure" xml:lang="en" id="feb412219-fig-0007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Transport data from radiolabeled efflux assays. The <styled-content style="fixed-case">SLC</styled-content>38A10 oocytes and control oocytes were injected with 23&#x000a0;nL of radiolabeled amino acid and the efflux was measured in 100&#x000a0;&#x003bc;L of transport buffer every 5&#x000a0;min for 30&#x000a0;min in count per minute (cpm) using scintillation counting. Unpaired t&#x02010;test with 95% confidence interval was performed, (*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, ***<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.001), (<italic>n</italic>&#x000a0;=&#x000a0;number of <styled-content style="fixed-case">SLC</styled-content>38A10 overexpressing oocytes; number of control oocytes), (A) <sc>l</sc>&#x02010;glutamine efflux assay at <styled-content style="fixed-case">pH</styled-content> 7.8, (measured efflux &#x000b1;<styled-content style="fixed-case">SD</styled-content>), <italic>n</italic>&#x000a0;=&#x000a0;6;6, [(5&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0011), (10&#x000a0;min, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (15&#x000a0;min, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (20&#x000a0;min, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (25&#x000a0;min <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (30&#x000a0;min, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001)]. (B) <sc>l</sc>&#x02010;glutamate efflux assay at <styled-content style="fixed-case">pH</styled-content> 7.8, (measured efflux &#x000b1;<styled-content style="fixed-case">SD</styled-content>), <italic>n</italic>&#x000a0;=&#x000a0;4;4, [(5&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0049), (10&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.004), (15&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0372), (20&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0398), (25&#x000a0;min <italic>P</italic>&#x000a0;=&#x000a0;0.0584), (30&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0340)]. (C) <sc>l</sc>&#x02010;alanine efflux assay at <styled-content style="fixed-case">pH</styled-content> 7.4, (measured efflux &#x000b1;<styled-content style="fixed-case">SD</styled-content>), <italic>n</italic>&#x000a0;=&#x000a0;7;7, [(5&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0004), (10&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0014), (15&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0002), (20&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0001), (25&#x000a0;min <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.0001), (30&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0001)], (D) <sc>l</sc>&#x02010;serine efflux assay at <styled-content style="fixed-case">pH</styled-content> 7.8, (measured efflux &#x000b1;<styled-content style="fixed-case">SD</styled-content>), [(5&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.1472), (10&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;5;5, <italic>P</italic>&#x000a0;=&#x000a0;0.0054), (15&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;5;6, <italic>P</italic>&#x000a0;=&#x000a0;0.1017), (20&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;6;6, <italic>P</italic>&#x000a0;=&#x000a0;0.0369), (25&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;5;6, <italic>P</italic>&#x000a0;=&#x000a0;0.00074), (30&#x000a0;min, <italic>n</italic>&#x000a0;=&#x000a0;5;6, <italic>P</italic>&#x000a0;=&#x000a0;0.0140)], (E) <sc>d</sc>&#x02010;aspartate efflux assay at <styled-content style="fixed-case">pH</styled-content> 7.8. (measured efflux &#x000b1;<styled-content style="fixed-case">SD</styled-content>), <italic>n</italic>&#x000a0;=&#x000a0;5 for both groups and times except <italic>n</italic>&#x000a0;=&#x000a0;6 for controls at 5 and 10&#x000a0;min [(5&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0003), (10&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0011), (15&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.0160), (20&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.2821), (25&#x000a0;min <italic>P</italic>&#x000a0;=&#x000a0;0.7074), (30&#x000a0;min, <italic>P</italic>&#x000a0;=&#x000a0;0.1307)].</p></caption><graphic id="nlm-graphic-15" xlink:href="FEB4-7-730-g007"/></fig></sec></sec><sec id="feb412219-sec-0022"><title>Discussion</title><p>In this paper, we have used pairwise global sequence alignments to determine the sequence identity between the SLC38 family members. SLC38A10 was predicted to have 11 transmembrane helices with an intracellular N&#x02010;terminal and a 722&#x02010;amino acid long C&#x02010;terminal on the outside of the membrane. Furthermore, immunoreactivity of SLC38A10 was located to inhibitory neurons and other neurons, as well as astrocytes, and the staining was abundant in the mouse brain. We show that the previously uncharacterized protein SLC38A10 is an amino acid transporter, with preference for <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamate, <sc>d</sc>&#x02010;aspartate, and <sc>l</sc>&#x02010;serine.</p><p>The immunostaining of SLC38A10 was abundant in mouse brain. More specifically, in the hippocampus, staining of SLC38A10 was located in cells in the granular layer of dentate gyrus <xref rid="feb412219-bib-0052" ref-type="ref">52</xref> and pyramidal cell layer of hippocampus, areas that support selective expression by excitatory neurons <xref rid="feb412219-bib-0053" ref-type="ref">53</xref>. Immunoreactivity was detected in the Purkinje cell layer in cerebellum, known to be GABAergic <xref rid="feb412219-bib-0054" ref-type="ref">54</xref>. In the brain, the previously studied SLC38 members are either expressed in neurons (SLC38A6 <xref rid="feb412219-bib-0033" ref-type="ref">33</xref>, SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>, SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref>, and SLC38A9 <xref rid="feb412219-bib-0034" ref-type="ref">34</xref>) or astrocytes (SLC38A3 <xref rid="feb412219-bib-0031" ref-type="ref">31</xref> and SLC38A5 <xref rid="feb412219-bib-0032" ref-type="ref">32</xref>), or in both neurons and glia (SLC38A1 <xref rid="feb412219-bib-0027" ref-type="ref">27</xref>, <xref rid="feb412219-bib-0028" ref-type="ref">28</xref> and SLC38A2 <xref rid="feb412219-bib-0030" ref-type="ref">30</xref>). Here, we detected SLC38A10 immunoreactivity in neurons and astrocytes (Fig.&#x000a0;<xref rid="feb412219-fig-0005" ref-type="fig">5</xref>), which resembles cell type localization for SLC38A1 and SLC38A2. We found this remarkable as SLC38A10 shared highest sequence identity with, SLC38A1 (23.1%) and SLC38A2 (24.7%), when looking at the TMH sequences. The SLC38A10 immunoreactivity was ubiquitous in astrocytes, while the neuronal staining was more cytoplasmic and more limited to the plasma membrane. In previous studies, intracellular immunoreactivity was detected for the plasma membrane&#x02010;bound transporters, SLC38A1 <xref rid="feb412219-bib-0055" ref-type="ref">55</xref> and SLC38A2 <xref rid="feb412219-bib-0056" ref-type="ref">56</xref>, in the trans&#x02010;Golgi Network, where the proteins later are recruited from to the plasma membrane. It has also been demonstrated that SLC38A1 and SLC38A2 exerts their function in the plasma membrane of neurons <xref rid="feb412219-bib-0038" ref-type="ref">38</xref>. Adaptive regulation and the movement of the transporters within cells are features for both system A and system N transporters <xref rid="feb412219-bib-0057" ref-type="ref">57</xref>. Trafficking of transporters within the cell regulates transport activity and one stimulus, for example, the amino acid levels, can induce movement of transporters to the plasma membrane and increase transport activity, while another can decrease activity and withdraw the transporter from the plasma membrane <xref rid="feb412219-bib-0011" ref-type="ref">11</xref>, <xref rid="feb412219-bib-0058" ref-type="ref">58</xref>. Nevertheless, the specific subcellular localization of SLC38A10, or the recruitment of SLC38A10 to the plasma membrane must be further studied.</p><p>The results from the transport data suggest SLC38A10 to be a bidirectional transporter for <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamate, <sc>l</sc>&#x02010;glutamine, and <sc>d</sc>&#x02010;aspartate, while efflux was measured for <sc>l</sc>&#x02010;serine. When measuring the transport of glutamine using different incubation times (5&#x02013;60&#x000a0;min), both significantly higher and lower uptake was measured in SLC38A10 oocytes, in a time&#x02010;dependent manner (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>A). These results indicated that SLC38A10 can mediate both uptake and efflux of glutamine. Bidirectional glutamine transport are reported for the system N transporters SLC38A3 <xref rid="feb412219-bib-0017" ref-type="ref">17</xref> and SLC38A5 <xref rid="feb412219-bib-0059" ref-type="ref">59</xref>. In our uptake studies we used amino acid concentrations at 1.2&#x000a0;&#x003bc;<sc>m</sc>, which are high compared to the endogenous levels in oocytes, which are in the range of 0.07&#x02013;3.6&#x000a0;n<sc>m</sc>
<xref rid="feb412219-bib-0060" ref-type="ref">60</xref>. It is possible that the uptake and the putative efflux phases of glutamine are a result of altered gradients for ions and substrates over time, and that SLC38A10 has the capacity to control the balance between intracellular and extracellular concentrations, resulting in periods of uptake and efflux. Our transport experiments do not measure the SLC38A10 <italic>K</italic>
<sub>m</sub> values. However, the <italic>K</italic>
<sub>m</sub> values have been measured for other family members, for example the <italic>K</italic>
<sub>m</sub> value for glutamine is 0.3&#x000a0;m<sc>m</sc> for SLC38A1 <xref rid="feb412219-bib-0027" ref-type="ref">27</xref> and 1&#x000a0;m<sc>m</sc> for SLC38A5 <xref rid="feb412219-bib-0059" ref-type="ref">59</xref>. Moreover, both lower and higher uptake of <sc>l</sc>&#x02010;glutamate was measured at 50&#x000a0;min for SLC38A10 oocytes compared with controls (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>B and D) using oocytes from different frogs. This phenomenon was observed several times, and the batch of oocytes affected the transport direction at a given time, although the pattern with increased and decreased uptake was consistent. This made it difficult to determine the substrate profile, by only rely on uptake assays, and therefore efflux assays were performed to substantiate the results. Efflux of <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;glutamate, and <sc>d</sc>&#x02010;aspartate was measured, as well as for <sc>l</sc>&#x02010;serine. SLC38A10 can most likely facilitate uptake of <sc>l</sc>&#x02010;serine as well, even though our uptake studies failed to show this, probably because we did not time the uptake phase correctly. It is also possible that this transporter do transport <sc>l</sc>&#x02010;aspartate, since both uptake and efflux of <sc>d</sc>&#x02010;aspartate was observed in competition with <sc>l</sc>&#x02010;aspartate (Fig.&#x000a0;<xref rid="feb412219-fig-0006" ref-type="fig">6</xref>C). The excitatory amino acid transporters (EAATs), from the SLC1 family, are nonselective toward <sc>l</sc>&#x02010; and <sc>d</sc>&#x02010;aspartate, while selective for <sc>l</sc>&#x02010;glutamate <xref rid="feb412219-bib-0061" ref-type="ref">61</xref>. The system A hallmark substrate MeAIB was transported, however, SLC38A10 also shares the efflux features with system N and it can as well translocate charged amino acids, which complicated the system classification. Moreover, alanine and glutamine are the two most common substrates transported by the SLC38 family members <xref rid="feb412219-bib-0011" ref-type="ref">11</xref>, but this is the second member that translocates the charged amino acids glutamate and aspartate. SLC38A8 also transports MeAIB and was classified to system A, although it transported charged amino acids <xref rid="feb412219-bib-0022" ref-type="ref">22</xref>. Taken together, SLC38A10 transport the paradigm substrates for system A, glutamine, alanine, and serine, as well as MeAIB, and hence, we suggest it to be classified to system A.</p><p>In the GGGC, the SLC38 proteins are suggested to mediate uptake of glutamine in neurons and efflux of glutamine from astrocytes. SLC38A3 <xref rid="feb412219-bib-0039" ref-type="ref">39</xref> and SLC38A5 <xref rid="feb412219-bib-0040" ref-type="ref">40</xref> are suggested to facilitate the glutamine flux from astrocytes, which are qualities possibly also shared by SLC38A10. In addition, SLC1A5 is also suggested to mediate glutamine flux from astrocytes <xref rid="feb412219-bib-0062" ref-type="ref">62</xref>. SLC38A1 <xref rid="feb412219-bib-0016" ref-type="ref">16</xref>, <xref rid="feb412219-bib-0027" ref-type="ref">27</xref>, <xref rid="feb412219-bib-0038" ref-type="ref">38</xref>, SLC38A2 <xref rid="feb412219-bib-0038" ref-type="ref">38</xref>, SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref>, and SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref> are suggested to enable glutamine uptake in the axon of neurons, close to the synaptic cleft. More specifically, SLC38A2 most likely facilitate uptake of glutamine in excitatory neurons <xref rid="feb412219-bib-0030" ref-type="ref">30</xref>, while this is mainly mediated by SLC38A1 in inhibitory neurons <xref rid="feb412219-bib-0055" ref-type="ref">55</xref>. Glutamine uptake can be facilitated by SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref> and SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref> in both inhibitory and excitatory neurons. In addition to immunoreactivity on axons, SLC38A7 <xref rid="feb412219-bib-0024" ref-type="ref">24</xref> and SLC38A8 <xref rid="feb412219-bib-0022" ref-type="ref">22</xref> are also intense on the soma, also suggesting a role in supplying neurons with glutamine for general biosynthesis. SLC38A10 has the capacity to facilitate glutamine uptake in neurons, and in addition mediate glutamine flux from astrocytes. It is also very remarkable that SLC38A10 transport the two most important excitatory amino acids in the brain, glutamate and aspartate. Therefore, SLC38A10 also have the capacity for glutamate uptake in neurons and astrocytes, following glutamate release from excitatory neurons, which are functions mediated by the EAATs <xref rid="feb412219-bib-0061" ref-type="ref">61</xref>. <sc>d</sc>&#x02010;serine function as a coagonist on the N&#x02010;methyl&#x02010;<sc>d</sc>&#x02010;aspartate (NMDA) receptor and the activation of the receptor requires binding of glutamate in combination with a coagonist. <sc>d</sc>&#x02010;serine is taken up by astrocytes and converted to <sc>l</sc>&#x02010;serine by the enzyme serine racemase (SR) <xref rid="feb412219-bib-0063" ref-type="ref">63</xref>. Although, <sc>l</sc>&#x02010;serine is also produced from glucose in glia cells <xref rid="feb412219-bib-0064" ref-type="ref">64</xref>. <sc>l</sc>&#x02010;serine is exported from astrocytes, a pathway suggested to be conducted by SLC1A4 <xref rid="feb412219-bib-0065" ref-type="ref">65</xref> and SLC1A5 <xref rid="feb412219-bib-0066" ref-type="ref">66</xref>. Furthermore, SLC1A4 and SLC1A5 are also transporters for <sc>d</sc>&#x02010;serine in rat hippocampal astrocytes <xref rid="feb412219-bib-0067" ref-type="ref">67</xref>. Effluxes of <sc>l</sc>&#x02010;serine were measured for SLC38A10 and it is possible that SLC38A10 transport <sc>l</sc>&#x02010;serine from astrocytes, to serve neurons with <sc>l</sc>&#x02010;serine for <sc>d</sc>&#x02010;serine synthesis <xref rid="feb412219-bib-0064" ref-type="ref">64</xref>. Glycine is also a coagonist on the NMDA receptor and SLC38A5 is suggested to mediate the glycine flux from astrocytes <xref rid="feb412219-bib-0040" ref-type="ref">40</xref>. Nevertheless, the subcellular localization where SLC38A10 exert its function need to be further studied. SLC38A10 have the highest TMH sequence identity with SLC38A2, although the sequence identity was in equal proportions (21.9&#x02013;24.7%) with SLC38A1, SLC38A3, SLC38A5, SLC38A7, and SLC38A8, and could thus have properties similar to them all, which supports our findings.</p><p>In conclusion, in the present study we show that SLC38A10 immunostaining is abundant in the mouse brain and the staining colocalized with markers for both neurons and astrocytes. We also show that the transporter is bidirectional and can mediate both uptake and efflux of <sc>l</sc>&#x02010;glutamine, <sc>l</sc>&#x02010;alanine, <sc>l</sc>&#x02010;glutamate, and <sc>d</sc>&#x02010;aspartate. In addition, efflux of <sc>l</sc>&#x02010;serine was measured. The results from the transport assays propose SLC38A10 to be classified into system A. Taken together, the cell type localization and the substrate profile for SLC38A10, suggests this transporter to have a potential role in pathways involved in both excitatory and inhibitory neurotransmission.</p></sec><sec id="feb412219-sec-0024"><title>Author contributions</title><p>SH wrote manuscript, planned and performed transport experiments, analysis and statistics of transport data, transmembrane predictions and sequence identity alignments, compiled figures. MH planned and analyzed IHC experiments and western blot, cloning, wrote the sections on western blot and IHC, compiled IHC and western blot figures. ME assisted with surgery of frogs, aided in analysis of transport data. RF drafted manuscript, planned experiments, conducted data analysis, conceived the study. All authors read and approved the final manuscript.</p></sec></body><back><ack id="feb412219-sec-0023"><title>Acknowledgements</title><p>Thanks to Gaetan Philippot for assistance with uptake assays. Thanks to Emelie Perland for assistance with bioinformatic analysis. Thanks to Viktoria Hindlycke, Erik L&#x000f6;fqvist, and Edvin Karlsson for assistance with immunohistochemistry and western blot experiments. This study was supported by the Swedish Research Council, Swedish Brain Foundation, Swedish Society for Medical Research, Novo Nordisk Foundation, &#x000c5;hlens Foundation, Olle Engkvist Foundation, Thurings Foundation for Metabolic Research, Gunvor and Josef An&#x000e9;rs Foundation, Tore Nilssons Foundation and Magnus Bergvalls Foundation.</p></ack><ref-list content-type="cited-references" id="feb412219-bibl-0001"><title>References</title><ref id="feb412219-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="feb412219-cit-0001">
<string-name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Clemencon</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Burrier</surname>
<given-names>RE</given-names>
</string-name> and <string-name>
<surname>Bruford</surname>
<given-names>EA</given-names>
</string-name> (<year>2013</year>) <article-title>The ABCs of membrane transporters in health and disease (SLC series): introduction</article-title>. <source>Mol Aspects Med</source>
<volume>34</volume>, <fpage>95</fpage>&#x02013;<lpage>107</lpage>.<pub-id pub-id-type="pmid">23506860</pub-id></mixed-citation></ref><ref id="feb412219-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="feb412219-cit-0002">
<string-name>
<surname>Amara</surname>
<given-names>SG</given-names>
</string-name> and <string-name>
<surname>Fontana</surname>
<given-names>AC</given-names>
</string-name> (<year>2002</year>) <article-title>Excitatory amino acid transporters: keeping up with glutamate</article-title>. <source>Neurochem Int</source>
<volume>41</volume>, <fpage>313</fpage>&#x02013;<lpage>318</lpage>.<pub-id pub-id-type="pmid">12176072</pub-id></mixed-citation></ref><ref id="feb412219-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="feb412219-cit-0003">
<string-name>
<surname>Hundal</surname>
<given-names>HS</given-names>
</string-name> and <string-name>
<surname>Taylor</surname>
<given-names>PM</given-names>
</string-name> (<year>2009</year>) <article-title>Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>296</volume>, <fpage>E603</fpage>&#x02013;<lpage>E613</lpage>.<pub-id pub-id-type="pmid">19158318</pub-id></mixed-citation></ref><ref id="feb412219-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="feb412219-cit-0004">
<string-name>
<surname>Kilberg</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>YX</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>Leung&#x02010;Pineda</surname>
<given-names>V</given-names>
</string-name> (<year>2005</year>) <article-title>Nutritional control of gene expression: how mammalian cells respond to amino acid limitation</article-title>. <source>Annu Rev Nutr</source>
<volume>25</volume>, <fpage>59</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">16011459</pub-id></mixed-citation></ref><ref id="feb412219-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="feb412219-cit-0005">
<string-name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Romero</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Rolfs</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takanaga</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>Bruford</surname>
<given-names>EA</given-names>
</string-name> (<year>2004</year>) <article-title>The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction</article-title>. <source>Pflugers Archiv: Europ J Physiol</source>
<volume>447</volume>, <fpage>465</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">14624363</pub-id></mixed-citation></ref><ref id="feb412219-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="feb412219-cit-0006">
<string-name>
<surname>Closs</surname>
<given-names>EI</given-names>
</string-name>, <string-name>
<surname>Simon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vekony</surname>
<given-names>N</given-names>
</string-name> and <string-name>
<surname>Rotmann</surname>
<given-names>A</given-names>
</string-name> (<year>2004</year>) <article-title>Plasma membrane transporters for arginine</article-title>. <source>J Nutrit</source>
<volume>134</volume>, <fpage>2752S</fpage>&#x02013;<lpage>2759S</lpage>; discussion 2765S&#x02010;2767S.<pub-id pub-id-type="pmid">15465780</pub-id></mixed-citation></ref><ref id="feb412219-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="feb412219-cit-0007">
<string-name>
<surname>Takamori</surname>
<given-names>S</given-names>
</string-name> (<year>2006</year>) <article-title>VGLUTs: &#x02018;exciting&#x02019; times for glutamatergic research?</article-title>
<source>Neurosci Res</source>
<volume>55</volume>, <fpage>343</fpage>&#x02013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">16765470</pub-id></mixed-citation></ref><ref id="feb412219-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="feb412219-cit-0008">
<string-name>
<surname>Rebsamen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pochini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Stasyk</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>de Araujo</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Galluccio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kandasamy</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Snijder</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fauster</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rudashevskaya</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Bruckner</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#x000a0;al</italic> (<year>2015</year>) <article-title>SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1</article-title>. <source>Nature</source>
<volume>519</volume>, <fpage>477</fpage>&#x02013;<lpage>481</lpage>.<pub-id pub-id-type="pmid">25561175</pub-id></mixed-citation></ref><ref id="feb412219-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="feb412219-cit-0009">
<string-name>
<surname>Visser</surname>
<given-names>WF</given-names>
</string-name>, <string-name>
<surname>van Roermund</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Waterham</surname>
<given-names>HR</given-names>
</string-name> and <string-name>
<surname>Wanders</surname>
<given-names>RJ</given-names>
</string-name> (<year>2002</year>) <article-title>Identification of human PMP34 as a peroxisomal ATP transporter</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>299</volume>, <fpage>494</fpage>&#x02013;<lpage>497</lpage>.<pub-id pub-id-type="pmid">12445829</pub-id></mixed-citation></ref><ref id="feb412219-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="feb412219-cit-0010">
<string-name>
<surname>Di Noia</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Todisco</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cirigliano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rinaldi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Agrimi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Iacobazzi</surname>
<given-names>V</given-names>
</string-name> and <string-name>
<surname>Palmieri</surname>
<given-names>F</given-names>
</string-name> (<year>2014</year>) <article-title>The human SLC25A33 and SLC25A36 genes of solute carrier family 25 encode two mitochondrial pyrimidine nucleotide transporters</article-title>. <source>J Biol Chem</source>
<volume>289</volume>, <fpage>33137</fpage>&#x02013;<lpage>33148</lpage>.<pub-id pub-id-type="pmid">25320081</pub-id></mixed-citation></ref><ref id="feb412219-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="feb412219-cit-0011">
<string-name>
<surname>Broer</surname>
<given-names>S</given-names>
</string-name> (<year>2014</year>) <article-title>The SLC38 family of sodium&#x02010;amino acid co&#x02010;transporters</article-title>. <source>Pflugers Archiv: Europ J Physiol</source>
<volume>466</volume>, <fpage>155</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">24193407</pub-id></mixed-citation></ref><ref id="feb412219-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="feb412219-cit-0012">
<string-name>
<surname>Mackenzie</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name> (<year>2004</year>) <article-title>Sodium&#x02010;coupled neutral amino acid (System N/A) transporters of the SLC38 gene family</article-title>. <source>Pflugers Archiv: Europ J Physiol</source>
<volume>447</volume>, <fpage>784</fpage>&#x02013;<lpage>795</lpage>.<pub-id pub-id-type="pmid">12845534</pub-id></mixed-citation></ref><ref id="feb412219-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="feb412219-cit-0013">
<string-name>
<surname>Christensen</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Oxender</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Vatz</surname>
<given-names>KA</given-names>
</string-name> (<year>1965</year>) <article-title>The use of N&#x02010;methylation to direct route of mediated transport of amino acids</article-title>. <source>J Biol Chem</source>
<volume>240</volume>, <fpage>3609</fpage>&#x02013;<lpage>3616</lpage>.<pub-id pub-id-type="pmid">5891075</pub-id></mixed-citation></ref><ref id="feb412219-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="feb412219-cit-0014">
<string-name>
<surname>Kilberg</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Handlogten</surname>
<given-names>ME</given-names>
</string-name> and <string-name>
<surname>Christensen</surname>
<given-names>HN</given-names>
</string-name> (<year>1980</year>) <article-title>Characteristics of an amino acid transport system in rat liver for glutamine, asparagine, histidine, and closely related analogs</article-title>. <source>J Biol Chem</source>
<volume>255</volume>, <fpage>4011</fpage>&#x02013;<lpage>4019</lpage>.<pub-id pub-id-type="pmid">7372663</pub-id></mixed-citation></ref><ref id="feb412219-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="feb412219-cit-0015">
<string-name>
<surname>Baird</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Pinilla&#x02010;Tenas</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Ogilvie</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hundal</surname>
<given-names>HS</given-names>
</string-name> and <string-name>
<surname>Taylor</surname>
<given-names>PM</given-names>
</string-name> (<year>2006</year>) <article-title>Evidence for allosteric regulation of pH&#x02010;sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity involving a conserved histidine residue</article-title>. <source>Biochem J</source>
<volume>397</volume>, <fpage>369</fpage>&#x02013;<lpage>375</lpage>.<pub-id pub-id-type="pmid">16629640</pub-id></mixed-citation></ref><ref id="feb412219-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="feb412219-cit-0016">
<string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Schmitz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Larsson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Nicoll</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kavanaugh</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Edwards</surname>
<given-names>RH</given-names>
</string-name> (<year>2002</year>) <article-title>Glutamine uptake by neurons: interaction of protons with system a transporters</article-title>. <source>J Neurosci</source>
<volume>22</volume>, <fpage>62</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">11756489</pub-id></mixed-citation></ref><ref id="feb412219-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="feb412219-cit-0017">
<string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Krizaj</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Storm&#x02010;Mathisen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Copenhagen</surname>
<given-names>DR</given-names>
</string-name> and <string-name>
<surname>Edwards</surname>
<given-names>RH</given-names>
</string-name> (<year>1999</year>) <article-title>Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission</article-title>. <source>Cell</source>
<volume>99</volume>, <fpage>769</fpage>&#x02013;<lpage>780</lpage>.<pub-id pub-id-type="pmid">10619430</pub-id></mixed-citation></ref><ref id="feb412219-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="feb412219-cit-0018">
<string-name>
<surname>Shotwell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Jayme</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Kilberg</surname>
<given-names>MS</given-names>
</string-name> and <string-name>
<surname>Oxender</surname>
<given-names>DL</given-names>
</string-name> (<year>1981</year>) <article-title>Neutral amino acid transport systems in Chinese hamster ovary cells</article-title>. <source>J Biol Chem</source>
<volume>256</volume>, <fpage>5422</fpage>&#x02013;<lpage>5427</lpage>.<pub-id pub-id-type="pmid">7240147</pub-id></mixed-citation></ref><ref id="feb412219-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="feb412219-cit-0019">
<string-name>
<surname>Sugawara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fei</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Martindale</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Leibach</surname>
<given-names>FH</given-names>
</string-name> and <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name> (<year>2000</year>) <article-title>Structure and function of ATA3, a new subtype of amino acid transport system A, primarily expressed in the liver and skeletal muscle</article-title>. <source>Biochem Biophys Acta</source>
<volume>1509</volume>, <fpage>7</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">11118514</pub-id></mixed-citation></ref><ref id="feb412219-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="feb412219-cit-0020">
<string-name>
<surname>Varoqui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ming</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name> (<year>2000</year>) <article-title>Cloning and functional identification of a neuronal glutamine transporter</article-title>. <source>J Biol Chem</source>
<volume>275</volume>, <fpage>4049</fpage>&#x02013;<lpage>4054</lpage>.<pub-id pub-id-type="pmid">10660562</pub-id></mixed-citation></ref><ref id="feb412219-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="feb412219-cit-0021">
<string-name>
<surname>Yao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mackenzie</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ming</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Varoqui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</string-name> and <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name> (<year>2000</year>) <article-title>A novel system A isoform mediating Na+/neutral amino acid cotransport</article-title>. <source>J Biol Chem</source>
<volume>275</volume>, <fpage>22790</fpage>&#x02013;<lpage>22797</lpage>.<pub-id pub-id-type="pmid">10811809</pub-id></mixed-citation></ref><ref id="feb412219-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="feb412219-cit-0022">
<string-name>
<surname>Hagglund</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Hellsten</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Bagchi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Philippot</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lofqvist</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Almkvist</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Karlsson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sreedharan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tafreshiha</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#x000a0;al</italic> (<year>2015</year>) <article-title>Transport of L&#x02010;glutamine, L&#x02010;alanine, L&#x02010;arginine and L&#x02010;histidine by the neuron&#x02010;specific Slc38a8 (SNAT8) in CNS</article-title>. <source>J Mol Biol</source>
<volume>427</volume>, <fpage>1495</fpage>&#x02013;<lpage>1512</lpage>.<pub-id pub-id-type="pmid">25451601</pub-id></mixed-citation></ref><ref id="feb412219-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="feb412219-cit-0023">
<string-name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kekuda</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fei</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Hatanaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sugawara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Martindale</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Leibach</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>PD</given-names>
</string-name> and <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name> (<year>2001</year>) <article-title>Cloning and functional characterization of a new subtype of the amino acid transport system N</article-title>. <source>Am J Physiol Cell Physiol</source>
<volume>281</volume>, <fpage>C1757</fpage>&#x02013;<lpage>C1768</lpage>.<pub-id pub-id-type="pmid">11698233</pub-id></mixed-citation></ref><ref id="feb412219-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="feb412219-cit-0024">
<string-name>
<surname>H&#x000e4;gglund</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Sreedharan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Shaik</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Almkvist</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Backlin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wrange</surname>
<given-names>O</given-names>
</string-name> and <string-name>
<surname>Fredriksson</surname>
<given-names>R</given-names>
</string-name> (<year>2011</year>) <article-title>Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons</article-title>. <source>J Biol Chem</source>
<volume>286</volume>, <fpage>20500</fpage>&#x02013;<lpage>20511</lpage>.<pub-id pub-id-type="pmid">21511949</pub-id></mixed-citation></ref><ref id="feb412219-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="feb412219-cit-0025">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tsun</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Wolfson</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wyant</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Plovanich</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Chantranupong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Comb</surname>
<given-names>W</given-names>
</string-name>
<italic>et&#x000a0;al</italic> (<year>2015</year>) <article-title>Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1</article-title>. <source>Science</source>
<volume>347</volume>, <fpage>188</fpage>&#x02013;<lpage>194</lpage>.<pub-id pub-id-type="pmid">25567906</pub-id></mixed-citation></ref><ref id="feb412219-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="feb412219-cit-0026">
<string-name>
<surname>Jung</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Genau</surname>
<given-names>HM</given-names>
</string-name> and <string-name>
<surname>Behrends</surname>
<given-names>C</given-names>
</string-name> (<year>2015</year>) <article-title>Amino acid&#x02010;dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9</article-title>. <source>Mol Cell Biol</source>
<volume>35</volume>, <fpage>2479</fpage>&#x02013;<lpage>2494</lpage>.<pub-id pub-id-type="pmid">25963655</pub-id></mixed-citation></ref><ref id="feb412219-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="feb412219-cit-0027">
<string-name>
<surname>Mackenzie</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schafer</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Weihe</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Varoqui</surname>
<given-names>H</given-names>
</string-name> (<year>2003</year>) <article-title>Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons</article-title>. <source>J Biol Chem</source>
<volume>278</volume>, <fpage>23720</fpage>&#x02013;<lpage>23730</lpage>.<pub-id pub-id-type="pmid">12684517</pub-id></mixed-citation></ref><ref id="feb412219-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="feb412219-cit-0028">
<string-name>
<surname>Melone</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Quagliano</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Barbaresi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Varoqui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name> and <string-name>
<surname>Conti</surname>
<given-names>F</given-names>
</string-name> (<year>2004</year>) <article-title>Localization of the glutamine transporter SNAT1 in rat cerebral cortex and neighboring structures, with a note on its localization in human cortex</article-title>. <source>Cereb Cortex</source>
<volume>14</volume>, <fpage>562</fpage>&#x02013;<lpage>574</lpage>.<pub-id pub-id-type="pmid">15054072</pub-id></mixed-citation></ref><ref id="feb412219-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="feb412219-cit-0029">
<string-name>
<surname>Weiss</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Derazi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rossignol</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Varoqui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Erickson</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Kilberg</surname>
<given-names>MS</given-names>
</string-name> and <string-name>
<surname>Anderson</surname>
<given-names>KJ</given-names>
</string-name> (<year>2003</year>) <article-title>Ontogeny of the neutral amino acid transporter SAT1/ATA1 in rat brain</article-title>. <source>Brain Res Dev Brain Res</source>
<volume>143</volume>, <fpage>151</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">12855186</pub-id></mixed-citation></ref><ref id="feb412219-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="feb412219-cit-0030">
<string-name>
<surname>Gonzalez&#x02010;Gonzalez</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Cubelos</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gimenez</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Zafra</surname>
<given-names>F</given-names>
</string-name> (<year>2005</year>) <article-title>Immunohistochemical localization of the amino acid transporter SNAT2 in the rat brain</article-title>. <source>Neuroscience</source>
<volume>130</volume>, <fpage>61</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">15561425</pub-id></mixed-citation></ref><ref id="feb412219-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="feb412219-cit-0031">
<string-name>
<surname>Boulland</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Rafiki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Storm&#x02010;Mathisen</surname>
<given-names>J</given-names>
</string-name> and <string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name> (<year>2003</year>) <article-title>Highly differential expression of SN1, a bidirectional glutamine transporter, in astroglia and endothelium in the developing rat brain</article-title>. <source>Glia</source>
<volume>41</volume>, <fpage>260</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">12528181</pub-id></mixed-citation></ref><ref id="feb412219-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="feb412219-cit-0032">
<string-name>
<surname>Cubelos</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gonzalez&#x02010;Gonzalez</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Gimenez</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Zafra</surname>
<given-names>F</given-names>
</string-name> (<year>2005</year>) <article-title>Amino acid transporter SNAT5 localizes to glial cells in the rat brain</article-title>. <source>Glia</source>
<volume>49</volume>, <fpage>230</fpage>&#x02013;<lpage>244</lpage>.<pub-id pub-id-type="pmid">15390093</pub-id></mixed-citation></ref><ref id="feb412219-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="feb412219-cit-0033">
<string-name>
<surname>Bagchi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Baomar</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Walai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Sadi</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Fredriksson</surname>
<given-names>R</given-names>
</string-name> (<year>2014</year>) <article-title>Histological analysis of SLC38A6 (SNAT6) expression in mouse brain shows selective expression in excitatory neurons with high expression in the synapses</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e95438</fpage>.<pub-id pub-id-type="pmid">24752331</pub-id></mixed-citation></ref><ref id="feb412219-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="feb412219-cit-0034">
<string-name>
<surname>Hellsten</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Lekholm</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Arapi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Perland</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Fredriksson</surname>
<given-names>R</given-names>
</string-name> (<year>2017</year>) <article-title>The gene expression of the neuronal protein, SLC38A9, changes in mouse brain after in&#x000a0;vivo starvation and high&#x02010;fat diet</article-title>. <source>PLoS One</source>
<volume>12</volume>, <fpage>e0172917</fpage>.<pub-id pub-id-type="pmid">28235079</pub-id></mixed-citation></ref><ref id="feb412219-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="feb412219-cit-0035">
<string-name>
<surname>Scalise</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pochini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Galluccio</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Indiveri</surname>
<given-names>C</given-names>
</string-name> (<year>2016</year>) <article-title>Glutamine transport. From energy supply to sensing and beyond</article-title>. <source>Biochimica et Biophysica Acta</source>
<volume>1857</volume>, <fpage>1147</fpage>&#x02013;<lpage>1157</lpage>.<pub-id pub-id-type="pmid">26951943</pub-id></mixed-citation></ref><ref id="feb412219-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="feb412219-cit-0036">
<string-name>
<surname>Walls</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Waagepetersen</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Bak</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Sonnewald</surname>
<given-names>U</given-names>
</string-name> (<year>2015</year>) <article-title>The glutamine&#x02010;glutamate/GABA cycle: function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism</article-title>. <source>Neurochem Res</source>
<volume>40</volume>, <fpage>402</fpage>&#x02013;<lpage>409</lpage>.<pub-id pub-id-type="pmid">25380696</pub-id></mixed-citation></ref><ref id="feb412219-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="feb412219-cit-0037">
<string-name>
<surname>Bak</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Waagepetersen</surname>
<given-names>HS</given-names>
</string-name> (<year>2006</year>) <article-title>The glutamate/GABA&#x02010;glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer</article-title>. <source>J Neurochem</source>
<volume>98</volume>, <fpage>641</fpage>&#x02013;<lpage>653</lpage>.<pub-id pub-id-type="pmid">16787421</pub-id></mixed-citation></ref><ref id="feb412219-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="feb412219-cit-0038">
<string-name>
<surname>Blot</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Billups</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bjorkmo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Quazi</surname>
<given-names>AZ</given-names>
</string-name>, <string-name>
<surname>Uwechue</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name> and <string-name>
<surname>Billups</surname>
<given-names>B</given-names>
</string-name> (<year>2009</year>) <article-title>Functional expression of two system A glutamine transporter isoforms in rat auditory brainstem neurons</article-title>. <source>Neuroscience</source>
<volume>164</volume>, <fpage>998</fpage>&#x02013;<lpage>1008</lpage>.<pub-id pub-id-type="pmid">19751803</pub-id></mixed-citation></ref><ref id="feb412219-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="feb412219-cit-0039">
<string-name>
<surname>Broer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Deitmer</surname>
<given-names>JW</given-names>
</string-name> and <string-name>
<surname>Broer</surname>
<given-names>S</given-names>
</string-name> (<year>2004</year>) <article-title>Astroglial glutamine transport by system N is upregulated by glutamate</article-title>. <source>Glia</source>
<volume>48</volume>, <fpage>298</fpage>&#x02013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">15390112</pub-id></mixed-citation></ref><ref id="feb412219-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="feb412219-cit-0040">
<string-name>
<surname>el Hamdani</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gudbrandsen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bjorkmo</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name> (<year>2012</year>) <article-title>The system N transporter SN2 doubles as a transmitter precursor furnisher and a potential regulator of NMDA receptors</article-title>. <source>Glia</source>
<volume>60</volume>, <fpage>1671</fpage>&#x02013;<lpage>1683</lpage>.<pub-id pub-id-type="pmid">22821889</pub-id></mixed-citation></ref><ref id="feb412219-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="feb412219-cit-0041">
<string-name>
<surname>Sundberg</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Waag</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jacobsson</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Stephansson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Rumaks</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Svirskis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Alsio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Roman</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ebendal</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Klusa</surname>
<given-names>V</given-names>
</string-name>
<italic>et&#x000a0;al</italic> (<year>2008</year>) <article-title>The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38</article-title>. <source>J&#x000a0;Mol Neurosci</source>
<volume>35</volume>, <fpage>179</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">18418736</pub-id></mixed-citation></ref><ref id="feb412219-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="feb412219-cit-0042">
<string-name>
<surname>Cedernaes</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Olszewski</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Almen</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Stephansson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Fredriksson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nylander</surname>
<given-names>O</given-names>
</string-name> and <string-name>
<surname>Schioth</surname>
<given-names>HB</given-names>
</string-name> (<year>2011</year>) <article-title>Comprehensive analysis of localization of 78 solute carrier genes throughout the subsections of the rat gastrointestinal tract</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>411</volume>, <fpage>702</fpage>&#x02013;<lpage>707</lpage>.<pub-id pub-id-type="pmid">21781957</pub-id></mixed-citation></ref><ref id="feb412219-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="feb412219-cit-0043">
<string-name>
<surname>Hagglund</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Roshanbin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lofqvist</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hellsten</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Todkar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Stephansson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Drgonova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Uhl</surname>
<given-names>GR</given-names>
</string-name>
<italic>et&#x000a0;al</italic> (<year>2013</year>) <article-title>B(0)AT2 (SLC6A15) is localized to neurons and astrocytes, and is involved in mediating the effect of leucine in the brain</article-title>. <source>PLoS One</source>
<volume>8</volume>, <fpage>e58651</fpage>.<pub-id pub-id-type="pmid">23505546</pub-id></mixed-citation></ref><ref id="feb412219-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="feb412219-cit-0044">
<string-name>
<surname>Mullen</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Buck</surname>
<given-names>CR</given-names>
</string-name> and <string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name> (<year>1992</year>) <article-title>NeuN, a neuronal specific nuclear protein in vertebrates</article-title>. <source>Development</source>
<volume>116</volume>, <fpage>201</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">1483388</pub-id></mixed-citation></ref><ref id="feb412219-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="feb412219-cit-0045">
<string-name>
<surname>Alirezaei</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kemball</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Flynn</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Whitton</surname>
<given-names>JL</given-names>
</string-name> and <string-name>
<surname>Kiosses</surname>
<given-names>WB</given-names>
</string-name> (<year>2010</year>) <article-title>Short&#x02010;term fasting induces profound neuronal autophagy</article-title>. <source>Autophagy</source>
<volume>6</volume>, <fpage>702</fpage>&#x02013;<lpage>710</lpage>.<pub-id pub-id-type="pmid">20534972</pub-id></mixed-citation></ref><ref id="feb412219-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="feb412219-cit-0046">
<string-name>
<surname>Bernhardt</surname>
<given-names>R</given-names>
</string-name> and <string-name>
<surname>Matus</surname>
<given-names>A</given-names>
</string-name> (<year>1984</year>) <article-title>Light and electron microscopic studies of the distribution of microtubule&#x02010;associated protein 2 in rat brain: a difference between dendritic and axonal cytoskeletons</article-title>. <source>J Comp Neurol</source>
<volume>226</volume>, <fpage>203</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">6736300</pub-id></mixed-citation></ref><ref id="feb412219-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="feb412219-cit-0047">
<string-name>
<surname>Kaufman</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Houser</surname>
<given-names>CR</given-names>
</string-name> and <string-name>
<surname>Tobin</surname>
<given-names>AJ</given-names>
</string-name> (<year>1991</year>) <article-title>Two forms of the gamma&#x02010;aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions</article-title>. <source>J&#x000a0;Neurochem</source>
<volume>56</volume>, <fpage>720</fpage>&#x02013;<lpage>723</lpage>.<pub-id pub-id-type="pmid">1988566</pub-id></mixed-citation></ref><ref id="feb412219-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="feb412219-cit-0048">
<string-name>
<surname>Reeves</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Helman</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Allison</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Israel</surname>
<given-names>MA</given-names>
</string-name> (<year>1989</year>) <article-title>Molecular cloning and primary structure of human glial fibrillary acidic protein</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>86</volume>, <fpage>5178</fpage>&#x02013;<lpage>5182</lpage>.<pub-id pub-id-type="pmid">2740350</pub-id></mixed-citation></ref><ref id="feb412219-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="feb412219-cit-0049">
<string-name>
<surname>von Overbeck</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stahli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gudat</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Carmann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lautenschlager</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Durmuller</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Takacs</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Miggiano</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Staehelin</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Heitz</surname>
<given-names>PU</given-names>
</string-name> (<year>1985</year>) <article-title>Immunohistochemical characterization of an anti&#x02010;epithelial monoclonal antibody (mAB lu&#x02010;5)</article-title>. <source>Virchows Archiv A, Pathol Anatomy Histopathol</source>
<volume>407</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="feb412219-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="feb412219-cit-0050">
<string-name>
<surname>Wiedenmann</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Franke</surname>
<given-names>WW</given-names>
</string-name> (<year>1985</year>) <article-title>Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles</article-title>. <source>Cell</source>
<volume>41</volume>, <fpage>1017</fpage>&#x02013;<lpage>1028</lpage>.<pub-id pub-id-type="pmid">3924408</pub-id></mixed-citation></ref><ref id="feb412219-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="feb412219-cit-0051">
<string-name>
<surname>Albers</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Broer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Setiawan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Kranz</surname>
<given-names>EU</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Broer</surname>
<given-names>S</given-names>
</string-name> (<year>2001</year>) <article-title>Na+ transport by the neural glutamine transporter ATA1</article-title>. <source>Pflugers Archiv: Europ J Physiol</source>
<volume>443</volume>, <fpage>92</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">11692272</pub-id></mixed-citation></ref><ref id="feb412219-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="feb412219-cit-0052">
<string-name>
<surname>Amaral</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name> and <string-name>
<surname>Lavenex</surname>
<given-names>P</given-names>
</string-name> (<year>2007</year>) <article-title>The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)</article-title>. <source>Prog Brain Res</source>
<volume>163</volume>, <fpage>3</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">17765709</pub-id></mixed-citation></ref><ref id="feb412219-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="feb412219-cit-0053">
<string-name>
<surname>Klausberger</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Somogyi</surname>
<given-names>P</given-names>
</string-name> (<year>2008</year>) <article-title>Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations</article-title>. <source>Science</source>
<volume>321</volume>, <fpage>53</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">18599766</pub-id></mixed-citation></ref><ref id="feb412219-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="feb412219-cit-0054">
<string-name>
<surname>McIntire</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Schuske</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Edwards</surname>
<given-names>RH</given-names>
</string-name> and <string-name>
<surname>Jorgensen</surname>
<given-names>EM</given-names>
</string-name> (<year>1997</year>) <article-title>Identification and characterization of the vesicular GABA transporter</article-title>. <source>Nature</source>
<volume>389</volume>, <fpage>870</fpage>&#x02013;<lpage>876</lpage>.<pub-id pub-id-type="pmid">9349821</pub-id></mixed-citation></ref><ref id="feb412219-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="feb412219-cit-0055">
<string-name>
<surname>Solbu</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Bjorkmo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Berghuis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Harkany</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name> (<year>2010</year>) <article-title>SAT1, A glutamine transporter, is preferentially expressed in GABAergic neurons</article-title>. <source>Front Neuroanat</source>
<volume>4</volume>, <fpage>1</fpage>.<pub-id pub-id-type="pmid">20161990</pub-id></mixed-citation></ref><ref id="feb412219-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="feb412219-cit-0056">
<string-name>
<surname>Hatanaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hatanaka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tsuchida</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name> and <string-name>
<surname>Setou</surname>
<given-names>M</given-names>
</string-name> (<year>2006</year>) <article-title>Amino acid transporter ATA2 is stored at the trans&#x02010;Golgi network and released by insulin stimulus in adipocytes</article-title>. <source>J Biol Chem</source>
<volume>281</volume>, <fpage>39273</fpage>&#x02013;<lpage>39284</lpage>.<pub-id pub-id-type="pmid">17050538</pub-id></mixed-citation></ref><ref id="feb412219-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="feb412219-cit-0057">
<string-name>
<surname>Ling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bridges</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Sugawara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Leibach</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>PD</given-names>
</string-name> and <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name> (<year>2001</year>) <article-title>Involvement of transporter recruitment as well as gene expression in the substrate&#x02010;induced adaptive regulation of amino acid transport system A</article-title>. <source>Biochem Biophys Acta</source>
<volume>1512</volume>, <fpage>15</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">11334620</pub-id></mixed-citation></ref><ref id="feb412219-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="feb412219-cit-0058">
<string-name>
<surname>Broer</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Gether</surname>
<given-names>U</given-names>
</string-name> (<year>2012</year>) <article-title>The solute carrier 6 family of transporters</article-title>. <source>Br J Pharmacol</source>
<volume>167</volume>, <fpage>256</fpage>&#x02013;<lpage>278</lpage>.<pub-id pub-id-type="pmid">22519513</pub-id></mixed-citation></ref><ref id="feb412219-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="feb412219-cit-0059">
<string-name>
<surname>Baird</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Beattie</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Hyde</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rennie</surname>
<given-names>MJ</given-names>
</string-name> and <string-name>
<surname>Taylor</surname>
<given-names>PM</given-names>
</string-name> (<year>2004</year>) <article-title>Bidirectional substrate fluxes through the system N (SNAT5) glutamine transporter may determine net glutamine flux in rat liver</article-title>. <source>J Physiol</source>
<volume>559</volume>, <fpage>367</fpage>&#x02013;<lpage>381</lpage>.<pub-id pub-id-type="pmid">15218073</pub-id></mixed-citation></ref><ref id="feb412219-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="feb412219-cit-0060">
<string-name>
<surname>Taylor</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Kaur</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mackenzie</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Peter</surname>
<given-names>GJ</given-names>
</string-name> (<year>1996</year>) <article-title>Amino&#x02010;acid&#x02010;dependent modulation of amino acid transport in <italic>Xenopus laevis</italic> oocytes</article-title>. <source>J Exp Biol</source>
<volume>199</volume>, <fpage>923</fpage>&#x02013;<lpage>931</lpage>.<pub-id pub-id-type="pmid">8788089</pub-id></mixed-citation></ref><ref id="feb412219-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="feb412219-cit-0061">
<string-name>
<surname>Kanai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Clemencon</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Simonin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Leuenberger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lochner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weisstanner</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</string-name> (<year>2013</year>) <article-title>The SLC1 high&#x02010;affinity glutamate and neutral amino&#x000a0;acid transporter family</article-title>. <source>Mol Aspects Med</source>
<volume>34</volume>, <fpage>108</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">23506861</pub-id></mixed-citation></ref><ref id="feb412219-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="feb412219-cit-0062">
<string-name>
<surname>Broer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brookes</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dimmer</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Broer</surname>
<given-names>S</given-names>
</string-name> (<year>1999</year>) <article-title>The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux</article-title>. <source>J Neurochem</source>
<volume>73</volume>, <fpage>2184</fpage>&#x02013;<lpage>2194</lpage>.<pub-id pub-id-type="pmid">10537079</pub-id></mixed-citation></ref><ref id="feb412219-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="feb412219-cit-0063">
<string-name>
<surname>Wolosker</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Dumin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Balan</surname>
<given-names>L</given-names>
</string-name> and <string-name>
<surname>Foltyn</surname>
<given-names>VN</given-names>
</string-name> (<year>2008</year>) <article-title>D&#x02010;amino acids in the brain: D&#x02010;serine in neurotransmission and neurodegeneration</article-title>. <source>FEBS J</source>
<volume>275</volume>, <fpage>3514</fpage>&#x02013;<lpage>3526</lpage>.<pub-id pub-id-type="pmid">18564180</pub-id></mixed-citation></ref><ref id="feb412219-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="feb412219-cit-0064">
<string-name>
<surname>Van Horn</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Sild</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Ruthazer</surname>
<given-names>ES</given-names>
</string-name> (<year>2013</year>) <article-title>D&#x02010;serine as a gliotransmitter and its roles in brain development and disease</article-title>. <source>Front Cellular Neurosci</source>
<volume>7</volume>, <fpage>39</fpage>.</mixed-citation></ref><ref id="feb412219-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="feb412219-cit-0065">
<string-name>
<surname>Sakai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Furuya</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name> (<year>2003</year>) <article-title>Neutral amino acid transporter ASCT1 is preferentially expressed in L&#x02010;Ser&#x02010;synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries</article-title>. <source>J Neurosci</source>
<volume>23</volume>, <fpage>550</fpage>&#x02013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">12533615</pub-id></mixed-citation></ref><ref id="feb412219-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="feb412219-cit-0066">
<string-name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nishizaki</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Furuya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hirabayashi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Okuyama</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</string-name> (<year>2003</year>) <article-title>Characterization of rapid and high&#x02010;affinity uptake of L&#x02010;serine in neurons and astrocytes in primary culture</article-title>. <source>FEBS Lett</source>
<volume>548</volume>, <fpage>69</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">12885409</pub-id></mixed-citation></ref><ref id="feb412219-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="feb412219-cit-0067">
<string-name>
<surname>Foster</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Farnsworth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lind</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YX</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Dang</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Penjwini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viswanath</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Staubli</surname>
<given-names>U</given-names>
</string-name> and <string-name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</string-name> (<year>2016</year>) <article-title>D&#x02010;Serine is a substrate for neutral amino acid transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and is transported by both subtypes in rat hippocampal astrocyte cultures</article-title>. <source>PLoS One</source>
<volume>11</volume>, <fpage>e0156551</fpage>.<pub-id pub-id-type="pmid">27272177</pub-id></mixed-citation></ref></ref-list></back></article>